Patent Grant
11963711
The present application relates generally to electrosurgical systems and methods. In particular, the present application pertains to electrosurgical systems with tissue and maximum current identification.
Electrosurgical devices and instruments are configured to use electrical energy to perform different surgical tasks. For example, electrosurgical instruments may include graspers, scissors, tweezers, blades, and/or needles that include one or more electrodes. These electrosurgical devices and instruments may be supplied with electrical energy from an electrosurgical generator. The electrical energy can then be used by the electrosurgical instrument to coagulate, fuse, and/or cut tissue.
Electrosurgical instruments typically fall within two classifications: monopolar and bipolar. Monopolar electrosurgical instruments supply the electrical energy to one or more electrodes on the electrosurgical instrument with high current density while a separate return electrode is electrically coupled to a patient. Monopolar electrosurgical instruments are designed to minimize current density. Monopolar electrosurgical instruments can also be useful in certain procedures but can include a risk of certain types of patient injuries such as electrical burns. The patient injuries can be at least partially attributable to functioning of the return electrode. In contrast, bipolar electrosurgical instruments use one or more electrodes that are electrically coupled to a source of electrical energy of a first polarity and one or more other electrodes that are electrically coupled to a source of electrical energy of a second polarity opposite the first polarity. In this way, bipolar electrosurgical instruments are configured to operate without separate return electrodes (as in the situation with monopolar electrosurgical instruments) and can therefore deliver electrical signals to a focused tissue area with reduced risks compared to monopolar electrosurgical instruments.
Even with the relatively focused surgical effects of using bipolar electrosurgical instruments, surgical outcomes can still be highly dependent on the skill of the user (e.g., surgeon) using the electrosurgical devices and instruments. For example, thermal tissue damage and necrosis can occur in instances where the electrical energy is delivered to an area of tissue for a relatively long duration or where a relatively high-powered electrical signal is delivered to the tissue even for a short duration. The rate at which a tissue will achieve a desired fusing, sealing, and/or cutting effect via the delivered electrical energy can vary based on a variety of different factors such as the tissue (e.g., type, volume), the pressure applied to the tissue by the electrosurgical instrument, the current state of the tissue, and/or the electrosurgical instrument being used. Thus, it can be difficult for the user (e.g., surgeon) of the electrosurgical instrument (even one who is skilled and experienced) to visually assess how quickly a mass of combined tissue types grasped via the electrosurgical instrument (e.g., monopolar or bipolar electrosurgical instrument) will become sealed. Furthermore, it can be difficult for the user (e.g., surgeon) to adjust the electrical energy being generated by the electrosurgical generator based on the same factors described above (e.g., tissue type, tissue volume, pressure, state of the tissue and/or electrosurgical instrument being used).
In accordance with various embodiments, an electrosurgical system is provided that is configured to monitor various information about tissue undergoing a sealing process in order to automatically modify the RF energy being applied to the tissue. In this way, the electrosurgical system can control how the RF energy is generated and transmitted from the electrosurgical generator to the electrosurgical instrument and how the electrosurgical instrument will apply the RF energy to the tissue. Furthermore, the electrosurgical system can monitor the progress of the sealing process and modify the generation and delivery of the RF energy to correspond to the state of the sealing process. In various other embodiments, the electrosurgical system can obtain various information about the tissue undergoing the sealing process and customize the aspects (e.g., voltage ramp, duration) about the sealing process.
The various features and embodiments provided throughout can be used alone, or in combination with other features and/or embodiments other than as expressly described and although specific combinations of embodiments and features or aspects of various embodiments may not be explicitly described such combinations however are contemplated and within the scope of the present inventions. Many of the attendant features of the present inventions will be more readily appreciated as the same becomes better understood by reference to the foregoing and following description and considered in connection with the accompanying drawings.
The present inventions may be better understood taken in connection with the accompanying drawings in which the reference numerals designate like parts throughout the figures thereof.
The present application pertains to an electrosurgical system that is configured to perform a variety of different surgical procedures such as fusing, cutting, and sealing tissue. The electrosurgical system includes at least an electrosurgical generator and a removably coupled electrosurgical instrument. The electrosurgical system is configured to obtain information about tissue undergoing the sealing process, calculate (in-real time) an appropriate amount of RF energy that will be provided to the electrosurgical instrument, and modify existing RF energy being generated to transmit to the electrosurgical instrument. The electrosurgical instrument is configured to use the provided RF energy in connection with the different surgical procedures (e.g., seal tissue).
As described in further details below, the calculations and determinations performed by the electrosurgical system can be based on a variety of different factors such as the electrosurgical instrument being used, the type, volume, and/or thickness of the tissue in contact with the electrosurgical instrument, and/or the surgical procedure being performed with the electrosurgical system. With the capabilities of the electrosurgical system, a variety of benefits will be realized (e.g., balance of hemostasis reliability, seal time, and tissue adherence) and will be further described below. Although the following application will primarily reference the electrosurgical system being used in connection sealing tissue, it should be noted that the electrosurgical system may be configured to be used in any number of other surgical procedures as well as in connection with a wide range of different tissues types, conditions, thicknesses, and/or volumes.
In one embodiment, the electrosurgical generator 10 may be configured to output RF energy in accordance to a variety of different parameters that include voltage, current, power, and/or phase (e.g., 375 VA, 150V, 5 A at 350 kHz). To calculate how much RF energy needs to be generated and determine how to transmit that RF energy (e.g., voltage profile), the electrosurgical generator may be configured to 1) measure the current and/or voltage associated with the RF energy currently being generated, 2) calculate a power measurement of the RF energy, and/or 3) calculate a phase angle or difference between the RF output voltage and the RF output current during activation or supply of the RF energy from the electrosurgical generator 10. Based on the calculations and determinations performed by the electrosurgical system, the electrosurgical generator 10 may also be instructed to regulate voltage, current, and/or power accordingly. For example, the electrosurgical generator 10 may be instructed to stop the output of the RF energy under pre-defined conditions such as when a device switch is de-asserted (e.g., fuse button is released), a time value is met, and/or a measured active phase angle, current, voltage, power and/or changes thereto is greater than, less than, or equal to a stop value, threshold, or condition and/or changes thereto.
As illustrated in
In accordance with various embodiments, the advanced bipolar instrument ports 12 may be configured to be coupled to an electrosurgical instrument (as illustrated in
The electrical power ports 14 may be configured to receive or be connected to a direct current (DC) accessory device that differs from the non-specialized bipolar electrosurgical instrument (connected to the standard bipolar instrument port 16) and the advanced bipolar electrosurgical instrument (connected to the advance bipolar instrument port 12). Specifically, the electrical power port 14 may be configured to supply direct current voltage (e.g., 12 Volts DC). The electrical power port 14 can also be configured to provide power to a surgical accessory, such as a respirator, pump, light, or any another surgical accessory. With the feature of the electrical power port 14, the electrosurgical device 10 is capable of replacing power supplies for surgical accessories. In some embodiments, replacing presently-existing generators and power supplies with the electrosurgical generator 10 described in this application can reduce the amount of storage space required on storage racks cards or shelves (e.g., reducing a number of power cords required in a surgical workspace).
The electrosurgical generator 10 can further comprise a display 15. The display 15 can be used to display a status of the electrosurgical system including, among other information, the status of the electrosurgical generator 10 (e.g., current RF energy output, measured parameters associated with the RF energy) and one or more connected electrosurgical instruments and/or accessories, connectors, or connections thereto.
The electrosurgical generator 10 can also comprise a user interface 17 that allows user interaction with the electrosurgical generator 10 such as, for example, requesting an increase or decrease in the amount of RF energy being supplied to one or more electrosurgical instruments coupled to the electrosurgical generator 10. In some embodiments, the user interface 17 may be implemented as a plurality of buttons (e.g., keyboard, number pad, arrows). In other embodiments, the user interface 17 can be integrated with the display 15 such that the display 15 is a touch screen display. The touch screen display would allow for the display of any status-related information as well as the buttons associated with carrying out the functions of the user interface 17.
In some embodiments, electrosurgical generator 10 can further comprise of one or more memory modules. The memory module may act as computer memory associated with the electrosurgical generator 10 and be used to store operational data concerning any number of different connected electrosurgical instruments. For example, in some embodiments, the operational data stored in the memory modules may include configuration-related information that can be used by a processor to configure/re-configure electrodes for the electrosurgical instruments. Other embodiments may have the operational data include information that can be used by the electrosurgical generator 10 to configure/re-configure processes of the electrosurgical generator 10 to work with/become compatible with the electrosurgical instruments. For example, the electrosurgical generator 10 may be configured based on the operational data to adjust operational time, voltage, power, phase and/or current settings, and/or adjust operational states, conditions, scripts, processes, or procedures pertaining to the surgical procedure being performed. Furthermore, the electrosurgical generator 10 (via the processor) can initiate read processes to obtain the operational data stored in the memory module (or stored in the memory module of connected electrosurgical instruments) to configure/re-configure the operation of the electrosurgical generator 10. The electrosurgical generator 10 can also initiate write processes to update and store operational data to the memory module (or memory modules of connected electrosurgical instruments) for later use.
To facilitate in the real-time calculations of how much RF energy should be generated and the determination of how the RF energy should provided to the electrosurgical instrument, one embodiment of the electrosurgical generator 10 has the electrosurgical generator 10 monitoring various parameters (e.g., voltage, current) and calculating the phase difference or phase angle of the RF energy currently being transmitted to the connected electrosurgical instrument. As such, while tissue is undergoing the sealing cycle, the monitored parameters and phase calculations from the electrosurgical system can be used to identify a current status of the sealing process (e.g., condition of the tissue) and whether the electrosurgical system should proceed to a different state, operation or step. As described below in further detail other mechanisms/methods (aside from using phase readings) can also be used to identify the current status of the sealing process and determine when the electrosurgical system should proceed through to subsequent steps/operations/states in the seal cycle.
In an embodiment, the electrosurgical generator 10 can be configured to monitor and measure a variety of different parameters (e.g., current, power, impedance, or power) associated with the RF output and calculate information (e.g., phase, power, thresholds) based on the same. By using the calculated information, the electrosurgical generator 10 can automatically configure how much RF energy should be generated and how the RF energy is being transmitted to any connected electrosurgical instrument. As an example, the electrosurgical generator may be able to adjust one or more parameters of the RF energy (e.g., adjusting a voltage level) that can influence the amount or how the RF energy (e.g., having an associated voltage profile) is being delivered to the electrosurgical instrument. As such, the electrosurgical system can control the output of the RF energy to the electrosurgical instrument thereby influencing how the sealing is performed on the tissue without involvement by a user (e.g., surgeon).
Once the electrosurgical generator 10 starts to deliver the RF energy to the connected electrosurgical instrument, the electrosurgical generator 10 can be configured to continue delivering the RF energy continuously (e.g., every 150 ms) until a fault occurs or a specific condition (e.g., % threshold, time period) is satisfied. In the situation where the fault occurs or the specific condition is satisfied (e.g., end of the sealing cycle), the electrosurgical generator 10 may transition to the next step or operation immediately. In some embodiments, the electrosurgical generator 10 may pause or wait a predetermined period of time (i.e. time delay) before commencing the next step or operation. Further details about the operations of the electrosurgical generator 10 in connection with the sealing of tissue (e.g., seal cycle) will be provided below.
With respect to
In some embodiments, the electrosurgical instrument 20 may include audio, tactile and/or visual indicators. The indicators allow the user (e.g., surgeon) to be apprised of information associated with the electrosurgical instrument 20 during a surgical procedure. For example, the information may include an indication (e.g., a beep, vibration, light) of a fusion, cut, and/or sealing operation being performed.
The actuator 24 provides means for a user (e.g., surgeon) to operate the electrosurgical instrument 20. For example, the actuator 24 may comprise a movable handle 23 and a stationary handle or housing 28. The movable handle 23 may be coupled and movable relative to the stationary handle or housing 28. In some embodiments, the movable handle 23 is slidably and pivotally coupled to the stationary handle or housing 28. In operation, the movable handle 23 is manipulated by the user (e.g., a surgeon) to actuate the jaw assembly 22, for example, selectively opening and closing each of the jaws of the jaw assembly 22 to release and grasp tissue therebetween.
In accordance with various embodiments, the actuator 24 may include a latch mechanism to allows the movable handle 23 to be maintained in a second position with respect to the stationary handle or housing 28. In various embodiments, the movable handle 23 comprises a latch arm which engages a matching latch contained within the stationary handle or housing 28. The latch arm is configured to hold the movable handle 23 at a second or closed position. The latch mechanism provides a feature for the electrosurgical instrument 20 whereby the jaw assembly 22 can remain closed (i.e. locked). This allows tissue that is grasped within the jaw assembly 22 to remain between the first and second jaws 31, 33 minimizing the scenario where the first and second jaws 31, 33 are accidentally released by the user during the surgical procedure.
The actuator 24 in various embodiments also comprises a wire harness that includes insulated individual electrical wires or leads contained within a single sheath. The wire harness can exit the stationary handle or housing 28 at a lower surface thereof and form part of the cabled connection (see reference 30 of
In various embodiments, the electrosurgical instrument 20 can also include a switch that is connected to a user manipulatable activation button 29. The switch can become activated when the activation button 29 is depressed. In one aspect, once activated, the switch completes an internal circuit by electrically coupling at least two leads together. The internal circuit acts as an electrical path from an electrosurgical generator to the actuator 24 and would be used as a way to transfer a supply of RF energy from the electrosurgical generator to, for example, the electrodes associated with the jaw assembly 22.
In various embodiments, the electrosurgical instrument 20 can also comprise a translatable mechanical cutting blade. The translatable mechanical cutting blade can be coupled to a blade actuator such as a blade lever or blade trigger 25 of the actuator 24. The mechanical cutting blade is actuated by the blade trigger 25 to divide the tissue between the jaws of the jaw assembly 22. When the user actuates (e.g., presses down on) the blade trigger 25, the translatable mechanical cutting blade (which is initially sheathed internally within a blade channel) can extend or become unsheathed towards the distal end of the elongate rotatable shaft 26. The blade channel can be positioned along one of the jaws of the jaw assembly 22. The unsheathing of the mechanical cutting blade provides the movement that allows for the cutting of tissue that is grasped between the jaw assembly 22 by the translatable mechanical cutting blade. The user (e.g., surgeon) is able to control the speed and depth of the cut based on the way the blade trigger 25 is pressed. Once the cut of the tissue has been completed, the user can release the blade trigger 25 thereby allowing the mechanical cutting blade to return back to a sheathed position within the blade channel.
In one embodiment, the actuator 24 includes a rotation shaft assembly including a rotation knob 27 which is disposed on an outer cover tube of the elongate rotatable shaft 26. The rotation knob 27 allows a user (e.g., surgeon) to rotate the elongate rotatable shaft 26 of the electrosurgical instrument 20 (and in turn the jaw assembly 22) while gripping the actuator 24. In accordance with various embodiments, the elongate rotatable shaft 26 comprises an actuation tube coupling the jaws of the jaw assembly 22 with the actuator 24. This feature may allow the user (e.g., surgeon) to position the jaws in an orientation that can be used to better grasp tissue.
As described above, attached to the distal end of the elongate rotatable shaft 26 are jaws of the jaw assembly 22. In particular, the jaw assembly 22 comprises a first (or upper) jaw 31 and a second (or lower) jaw 33. One or both of the jaws of the jaw assembly 22 are movable/pivotable in response to user interaction with the actuator 24 (e.g., moving the movable handle 23 to a position proximate to the stationary handle or housing 28. In one embodiment, a jaw pivot pin pivotally couples the first jaw 31 and the second jaw 33 and allows one of the jaws (e.g., the first jaw 31) to be movable and pivotable relative to the other jaw (e.g., the second jaw 33). In other embodiments, one jaw (e.g., the first jaw 31) can be fixed with respect to the elongate rotatable shaft 26 such that the opposing jaw (e.g., the second jaw 33) pivots with respect to the fixed jaw (e.g., the first jaw 31) between an open and a closed position. In another embodiment, both the first and second jaws 31, 33 can be pivotally coupled to the elongate rotatable shaft 26 such that both the first and second jaws 31, 33 can pivot with respect to each other.
The first (or upper) jaw 31 may include an electrode (e.g., plate or pad). Similarly, the second (or lower) jaw 33 may also include an electrode (e.g., plate or pad). The electrode of the first jaw 31 and the electrode of the second jaw 33 may be electrically coupled to the electrosurgical generator via wires and connectors. The electrodes of the first and second jaws 31, 33 are arranged to have opposing polarity and to transmit RF energy therebetween. In this way, the electrosurgical generator can supply RF energy to tissue grasped between the electrodes of the first and second jaws 31, 33.
The first jaw 31 in various embodiments can also include an upper jaw support with an assembly spacer positioned between the first jaw support and the electrode connected to the first jaw 31. In some embodiments, the first jaw 31 can include an overmold while in some other embodiments, the first jaw 31 is overmolded. In addition, the second jaw 33 can include a lower jaw support and the electrode. In the illustrated embodiment, the electrode is integrated or incorporated in the lower jaw support and thus the lower jaw support and the electrode form a monolithic structure and electrical connection.
In connection with cutting tissue, the blade channel can extend longitudinally along the length of the first jaw 31, the second jaw 33, or both the first and second jaws 31, 33 through which the mechanical cutting blade operationally traverses. Surrounding a portion of the blade channel are one or more conductive posts. The conductive posts assist in strengthening the blade channel and support the tissue to be cut. The conductive posts also assist in ensuring the tissue being cut adjacent or proximate to the blade channel is fused as the conductive posts also participate in the transmission of RF energy to the tissue grasped between the first and second jaws 31, 33. Much like the first jaw 31, some embodiments may have the second jaw 33 include an overmold while other embodiments the second jaw 33 is overmolded.
In accordance with various embodiments, the electrodes associated with the first and second jaws 31, 33 may each have a generally planar sealing surface arranged to atraumatically contact and compress tissue captured between the first and second jaws 31, 33. In some embodiments, the electrodes of the first and second jaws 31, 33 have a seal surface in which the width of the seal surface is uniform, constant, or remains unchanged throughout.
In various embodiments, the first and second jaws 31, 33 may be curved to increase visualization and mobility of the first and second jaws 31, 33 at the targeted surgical site and during the surgical procedure (e.g., sealing tissue). The first and second jaws 31, 33 may have a proximal elongate portion that is denoted or aligned with straight lines and a curved distal portion denoting or defining a curve that is connected to the straight lines. In various embodiments, the proximal most portion of the proximal elongate portion has or delimits a diameter that equals or does not exceed a maximum outer diameter of the first and second jaws 31, 33 or elongate rotatable shaft 26. The first and second jaws 31, 33 in various embodiments may have a maximum outer diameter in which the proximal most portion of the jaw assembly 22 and the distal most portion of the jaw assembly 22 remains within the maximum outer diameter. The curved distal portion has or delimits a diameter that is smaller than the maximum outer diameter and the diameter of the proximal most portion of the proximal elongate portion. In various embodiments, the first and second jaws 31, 33 may have a deeper inner curve cut-out than the outer curve and in various embodiments the tip of the first and second jaws 31, 33 are tapered for blunt dissection. The jaw assembly 22 can include a blade channel having a proximal elongate channel curving to a distal curved channel in which the proximal elongate channel is parallel and offset to the longitudinal axis of the elongate rotatable shaft 26 of the electrosurgical instrument 20. As such, visibility and mobility at the first and second jaws 31, 33 are maintained or enhanced without increasing jaw dimensions as increase jaw dimensions may further reduce the surgical working area or require larger access devices or incisions into the patient's body.
In some embodiments, electrode geometry of the conductive pads of the jaw assembly 22 ensures that the sealing area or surface completely encloses the distal portion of the cutting path. In accordance with various embodiments, the dimensions of the surfaces of the first and second jaws 31, 33 are such that it is appropriately proportioned with regards to the optimal pressure applied to the tissue between the first and second jaws 31, 33 for the potential force the force mechanism can create. The surface area of the jaw assembly 22 is also electrically significant with regards to the surface area contacting the tissue. This proportion of the surface area and the thickness of the tissue have been optimized with respect to its relationship to the electrical relative properties of the tissue.
In various embodiments, the second (or lower) jaw 33 and an associated conductive pad have an upper outer surface arranged to be in contact with tissue. The upper surfaces are angled or sloped and mirror images of each other with such positioning or orientation facilitating focused current densities and securement of tissue. In various embodiments, the second jaw 33 is made of stainless steel and is as rigid as or more rigid than the conductive pad. In various embodiments, the second jaw 33 comprises rigid insulators made of a non-conductive material and are as rigid as or more rigid than the second jaw 33 or the conductive pad. In various embodiments, the second jaw 33 and the conductive pad are made of the same material.
Generally, the RF amplifier 42 can be used to generate the RF energy that will be provided to the electrosurgical instrument 20 in connection with the surgical procedures (e.g., sealing tissue). For example, the RF amplifier 42 can be configured to convert 100V DC from the power supply 41 into a sinusoidal waveform with a frequency of 350 kHz. The converted RF energy can then be delivered to the electrosurgical instrument 20 where the RF energy is applied to tissue in contact with the electrosurgical instrument in connection with a sealing process.
The electrosurgical generator 10 may also include a RF sense circuitry 43. The RF sense circuitry 43 provides the electrosurgical generator the capability to monitor and measure various different parameters (e.g., voltage, current, power, phase) of the RF energy as well as perform calculations based on the measurements. Generally, the RF sense circuitry 43 can be configured to measure parameters (e.g., voltage, current) in analog, convert the analog measurements to a digital format, process the measurements via an FPGA to calculate RMS values associated with the measured parameters, calculate apparent power and phase angle, and convert the digital data back to analog for use by the controller 44.
In art embodiment, the RF sense circuitry 43 can be configured to monitor the voltage and current of RF energy coming from the RF amplifier 42. After obtaining the measurements, the RF sense circuitry 43 can perform a number of calculations based on the measurements such as the root means square (RMS) of the voltage and current, apparent power of the RF output energy, and the phase angle between the voltage and current of the RF energy being supplied through the connected electrosurgical instrument 20. The calculations can be performed using analog circuitry associated with the RF sense circuitry 43 to generate real and imaginary components of both voltage and current. The information associated with the calculations are processed by a field-programmable gate array (FPGA). Ultimately, the RF sense circuitry 43 will aim to generate signals that can be sent to the controller 44 for further processing.
As noted above, the information produced by the RF sense circuitry 43 can be provided to a controller 44. In various embodiments, the controller 44 controls or signals to the RF amplifier 42 whether any changes to the RF energy need to be made and/or how to modify the RF energy being provided to the electrosurgical instrument 20. For example, the controller 44 can utilize the information provided by the RF sense circuitry 43 to determine if the RF energy being provided via the RF amplifier 42 should be outputted as is, adjusted, or terminated. In one embodiment, the controller 44 determines if or when a predetermined current, power, and/or phase threshold has been reached or exceeded. When a threshold has been reached or exceeded, the controller 44 can use this detected event to determine, for example, the current state of the surgical process, what how the RF energy should be adjusted to correspond to the next step of the surgical process, and whether to terminate the output of RF energy. In various embodiments, the controller 44 is configured to assist in the surgical process (e.g., sealing process of tissue) by detecting various thresholds and providing instructions that control the RF energy output based on what step of the surgical process is being performed. In other embodiments, the controller 44 can be configured to receive instructions, settings, and/or script data to assist in the performance of the surgical process (e.g., sealing process) from a memory module. The memory module may be associated with the electrosurgical generator 10. In some cases, the memory module may be associated with the electrosurgical instrument 20.
As an example, different thresholds may be associated with different conditions associated with a particular type of tissue during a sealing process. As the tissue undergoes sealing, fluid/water is removed from the tissue so that the tissue can be cut and/or fused together. As the remaining amount of fluid/water is removed from the tissue (corresponding to different stages of the sealing process), a corresponding threshold (e.g., measured current) can be used to signify when the current stage is detected. The thresholds can then be used to modify (e.g., reduce) an amount of RF energy that is provided to the tissue. For example, as the tissue becomes more desiccated, less energy would be necessary to remove the remaining fluid/water within the tissue. In controlling the RF energy, the electrosurgical generator 10 can minimize the possibility of damaging the tissue via, for example, burning thereby minimizing recovery time for the patient.
In some embodiments, the controller 44 may include an operations engine that enables the electrosurgical generator 10 to be configurable to accommodate different operational scenarios (e.g., different electrosurgical instruments, different surgical procedures, different user preferences). For example, the operations engine of the controller 44 can be configured to receive and interpret data from the memory module (e.g., pluggable memory device inserted into the electrosurgical generator 10 or associated with the electrosurgical instrument 20). Information (e.g., configuration data) stored therein can be used to configure the electrosurgical generator 10. For example, the information can define state logic used by the electrosurgical generator 10, define and/or set output levels for the RF energy, define and/or set shutoff criteria for the RF energy, identify error conditions (e.g., electrical short circuit condition, electrical open circuit condition).
The RF sense circuitry 43 and the controller 44 work together in order to ensure that parameters associated with the currently outputted RF energy are within predefined threshold ranges or windows. Example threshold ranges or windows can be delimited by predetermined maximum and minimum voltages, currents, phases, and/or power that correspond to expected conditions associated with the currently outputted RF energy. In some cases, if measurements of one or more parameters (e.g., voltage, current, phase, power) are found to be outside the predefined threshold range or window, an error can be identified and the user is subsequently notified accordingly. In other cases, measurements found to be outside of the predefined threshold range or window can be used to identify transitioning to a next step of the surgical process. Accordingly, the predefined threshold range or window can then be adjusted accordingly based on the next step being transitioned to. In another case, if the predefined threshold range or window is breached, the electrosurgical system can be instructed to terminate (e.g., end the supply of RF energy) immediately or after a pre-determined period of time.
In accordance with various embodiments, the controller 44 can be configured to provide regulation control of various parameters (e.g., voltage, current, power and/or phase) or functions related to the output of the RF energy by the RF amplifier 42. For example, the controller 44 can be configured to utilize one or more of the parameters or functions in order to determine when and how to adjust the output of RF energy. In one exemplary embodiment, the controller 44 can be configured to provide regulation controls for direct regulation of one or more parameters that, when adjusted, would satisfy specific thresholds (e.g., regulation set points).
In accordance with various embodiments, the electrosurgical generator 10 can use the monitored, measured and/or calculated values of parameters (e.g., voltage, power, current and/or phase) associated with the RF energy as control indicators to identify a current state of the surgical process (e.g., condition of the tissue such as the tissue reaching a point of desiccation or an estimate amount of fluid/water that still needs to be removed from the tissue) as well as identify next steps to be performed in the surgical process (e.g., adjusting the amount of RF energy being applied to the tissue in the sealing process). In various embodiments, additional measurements or calculations based on the measured values related to RF output regulation circuitry can be provided via a script that can be used to recognize and act upon additional or different events related to or triggered by the additional measurements or calculations. The additional measurements described above may include error signals in combination with a pulse width modulation (PWM) duty cycle that is used to regulate various RF energy output parameters (e.g., voltage, current and/or power). Different or additional events or indicators that could be identified and triggered in various embodiments could be used as transitions from one regulation control to another regulation control (e.g. changing from current regulation to power regulation).
In various embodiments, the electrosurgical generator 10 can be configured to utilize many states, control points, or checks corresponding to different steps of a surgical process. The electrosurgical generator 10 can identify which state, control point, or check is present based on identifying a current parameter value (e.g., phase, current, or power) and determining whether the parameter value is expected for the present state, control point or check or for a different state, control point or check. Furthermore, the electrosurgical generator 10 can be configured to evaluate whether a change in the current parameter value has a positive or negative trend to determine whether the next state, control point, or check is to be expected to occur soon. An error can be signaled if the electrosurgical generator 10 does not identify an expected or predefined trend. The use of the multiple states, control points and checks and/or circuitry related thereto increase or enhance the resolution associated with the electrosurgical generator in identifying an expected RF output trend over different types of tissue.
The electrosurgical generator 10 can also be configured to detect the occurrence of an electrical open or short circuit condition. The electrosurgical generator 10 is able to do so by monitoring, for example, the phase or current and/or rate of change associated with the phase or current. In one example, the electrosurgical generator 10 can be configured to identify that an electrical short condition of the connected electrosurgical instrument 20 is present by monitoring the phase of the outputted RF energy and determining that the monitored phase is greater than a predefined maximum phase value. Similarly, the electrosurgical generator 10 can also identify whether an electrical open condition is present in the connected electrosurgical instrument 10 by monitoring the current of the outputted RF energy and determining that the monitored current is less than a predefined minimum current. For both scenarios, the detection of the short or open circuit condition causes the electrosurgical generator 10 to flag that an error is present. Furthermore, the electrosurgical generator 10 can terminate/halt the RF energy being supplied to the connected electrosurgical instrument 20 by, for example, signaling the RF amplifier to halt supply of RF energy or deactivating a relay or switch connected to the output port of the generator.
Up to this point, the present application has described different aspects of the electrosurgical system—in particular, the features of the electrosurgical generator and the electrosurgical instrument. Details will now be provided with respect to the use of the electrosurgical system in connection with surgical procedures (e.g., sealing tissue). Although sealing tissue will be used as the exemplary surgical procedure in connection with the electrosurgical system, one skilled in the art can configure the described electrosurgical system herein to be compatible with other surgical procedures.
During an exemplary sealing process, the user (e.g., surgeon) may visually identify/select a portion of tissue that the user intends to seal. Once the tissue has been identified/selected, the jaw assembly 22 of the electrosurgical instrument 22 (e.g., the first and second jaws 31, 33) can be placed around the identified/selected tissue. The movable handle 23 can then be maneuvered to the closed position so as to have the first and second jaws 31, 33 clamp together to effectively grasp the tissue. Once the tissue has been grasped within the jaw assembly 22, the depression of the activation button 29 by the user (e.g., surgeon) can initiate the sealing process on the tissue by allowing for the application of the RF energy coming from the electrosurgical generator 10. When the tissue has been completed sealed, the jaw assembly can be reopened thereby releasing the tissue from the jaw assembly 22. The jaws of the electrosurgical instrument 20 can be opened to relieve compression on tissue being grasped by the jaws at any time (e.g., before or after the application of the RF energy). Further details on how the electrosurgical system (e.g., the electrosurgical generator 10) manages/modifies the RF energy being generated/supplied to seal the tissue via the electrosurgical instrument 20 will be provided below.
In accordance with various embodiments, the electrosurgical instrument 20 may have a first (i.e., open) state in which the first and second jaws 31, 33 are spaced from each other and thus the movable handle 23 is also spaced from the stationary handle or housing 28. The electrosurgical instrument 20 can then be positioned to have tissue in between the first and second jaws 31, 33 thereby allowing the electrosurgical instrument to grasp tissue between the first and second jaws 31, 33. In the second (i.e., intermediate) state of the electrosurgical instrument 20, the first and second jaws 31, 33 are proximate to each other thereby grasping tissue between the first and second jaws 31, 33. In this second state, the movable handle 23 and the stational handle or housing 28 are proximate to each other. The user (e.g., surgeon) can revert back to the first state by opening the jaw assembly 22 thereby allowing the user to again position the jaw assembly 22 to grasp the same area of tissue or grasp a different area of tissue altogether. In the third (i.e., closed) state of the electrosurgical instrument 20, the movable handle 23 is moved further closer to the stationary handle or housing 28 and latches to the stationary handle or housing 28. In some embodiments, the latching of the movable handle 23 to the stationary handle or housing 28 can lock the jaw assembly 22. With the movement to the third state, the tissue grasped between the jaw assembly 22 can be held in place. In this way, movement to the third state, in which the movable handle 23 is latched to the stationary handle or housing 28, reduces the potential event of unintentionally releasing the tissue. Furthermore, the third state can allow the tissue to be cut through via the activation of the blade trigger 25. The latching of the movable handle 23 to keep the grasped tissue in place also minimizes inadvertent cutting of tissue or along the wrong tissue lines. In some embodiments, the ability to cut tissue may only be allowed when the movable handle 23 is latched to the stationary handle or housing 28. Additionally, the third (closed) state allows the application of constant, continuous, and predefined compression or range of compression on the tissue between the first and second jaws 31, 33 before, during, and after the activation of the RF energy, thereby enhancing the sealing of the tissue between the first and second jaws 31, 33. In accordance with various embodiments, the application of RF energy can occur once the movable handle 23 and the jaw assembly 22 are in at least the second state and once the activation button 29 is activated by the user (e.g., surgeon). In some embodiments, the application of RF energy may only be allowed once the electrosurgical instrument is in the third state (e.g., the movable handle is latched to the stationary handle thereby locking the tissue in between the first and second jaws 31, 33).
In various embodiments, an intermediate or unlatched position is provided in which the first and second jaws 31, 33 are in a closed or proximate position but the movable handle 23 is unlatched. As such, if the movable handle 23 is released, the movable handle 23 will return to its original or initial position. In one embodiment, while the movable handle 23 is unlatched, the blade trigger 25 may not be capable of being activated to cut tissue between the first and second jaws 31, 33 but the activation button 29 may still be capable of being activated to seal tissue between the first and second jaws 31, 33. In various embodiments, a latched position is provided in which the first and second jaws 31, 33 are in a closed or proximate position and the movable handle 23 is latched. As such, if the movable handle 23 is released, the movable handle 23 will not return to its original or initial position thereby keeping the first and second jaws 31, 33 in the closed or proximate position. In one embodiment, while the movable handle 23 is latched, the activation button 29 may be capable of being activated to seal tissue between the closed jaw assembly 22 and/or the blade trigger 25 may be capable of being activated to cut tissue between the first and second jaws 31, 33.
In another process, the user (e.g., surgeon) can cut tissue between the first and second jaws 31, 33 of the electrosurgical instrument by actuating the blade trigger 25. When the blade trigger 25 is moved proximally, a cutting blade moves distally within a blade channel to divide the tissue between the jaw assembly 22. When the user (e.g., surgeon) releases the blade trigger 25, the blade spring resets the cutting blade to its original position (e.g., sheathed position within the blade channel). In accordance with various embodiments, the actuator 24 may have a cut condition in which the first and second jaws 31, 33 are in a closed position and the movable handle 23 is closed and latched before the depressing of the blade trigger 25 will allow for the advancing of the cutting blade to its distal most position.
Provided below will be a general overview of the sealing process as well as a more detailed explanation in connection with the electrosurgical system described herein. Generally sealing tissue can involve first heating the tissue to an appropriate temperature where fluid/water within the tissue begins to vaporize (i.e., desiccation). The heating is carried out by providing an amount of RF energy with a high voltage ramp. This allows the temperature to be heated quickly.
Tissue fusion can generally occur around 60° C. as that's the temperature where collagen crosslinking begins to occur. To create a strong and durable seal, fluid/water must be removed from the tissue. The removal of the fluid/water allows the collagen and other protein structures in the tissue to crosslink with the rest of the biological structures of the tissue to create the durable seal. With the presence of fluid/water in the tissue, the collagen crosslinking will result in a gelatin-like substance which is less durable.
Once the vaporization of the fluid/water has been detected, the supply of the RF energy can be modified so that the temperature of the tissue is maintained at the current temperature to allow the vaporization of the fluid/water to continue at a controlled rate while preventing the possibility that the tissue becomes overheated. Furthermore, removal of the fluid/water too quickly from the tissue can create steam that can tear apart tissue and damage the seal being created.
Once all the fluid/water has been removed from the tissue, the RF energy being supplied to the tissue can be terminated. At this point, the sealing of the tissue has been completed.
With respect to the flowchart illustrated in
First, the electrosurgical system may begin with having the electrosurgical generator supply the RF energy to a connected electrosurgical instrument (71). The electrosurgical generator may initially set parameters associated with the generation of the RF energy being provided to the electrosurgical instrument. For example, the electrosurgical generator may generate the RF energy to have an initial voltage profile that has a steep voltage ramp (72). The initial parameters (e.g., voltage profile) may be default parameters for the electrosurgical generator. In some embodiments, operational data can be provided (e.g., by a user) to the electrosurgical generator that instructs how the electrosurgical system should generate the RF energy (e.g., data stored in a memory module, user input via the user interface). As an example, the RF energy may have a voltage profile that corresponds to an increase in voltage from an initial value of 40V to a maximum value of 60V over a pre-defined period of time (e.g., 75 ms). In another example, the voltage profile for the RF energy could be implemented instead by increasing current from an initial value of 2500 mA to a maximum value of 5000 mA over the same pre-defined period of time (e.g., 75 ms).
As the RF energy is being applied in the ramping manner (via 71 and 72) to the tissue during the initial period of time, the electrosurgical system can be monitoring one or more different parameters (e.g., voltage, current, phase, power) associated with the RF energy being applied to the tissue to detect when an RF output peak condition (73) has occurred. The electrosurgical system can then use the measured maximum current associated with the RF output peak condition to track a progress of the tissue undergoing the sealing process and manage the RF energy being used (as described below).
In one embodiment, the RF output peak condition can be detected by the electrosurgical system when one or more of the monitored parameters (e.g., voltage, current, phase, power) reaches a maximum value or peak. For example, the RF output peak condition can be identified (in 73) by monitoring the current being drawn into the tissue and identifying when the maximum amount of current has been drawn.
The electrosurgical system can also be configured to determine if a double seal/repeat seal condition is present (74). Double seal/repeat seal conditions correspond to situations where the tissue currently undergoing the sealing process was previously sealed. Previously sealed tissue already had some or all of the fluid/water removed from the tissue thereby requiring less RF energy to complete the seal. Therefore, the electrosurgical system is capable of identifying when to reduce the application of RF energy for the tissues that have already undergone one or more activations (e.g., previous sealing cycles). In doing so, the electrosurgical system can minimize or avoid negative effects such as eschar (sealed tissue debris) buildup, tissue adherence, and/or thermal spread.
To determine whether a double seal/repeat seal condition is present (in 74), the electrosurgical generator can monitor one or more parameters associated with the RF energy currently being applied to the tissue. A comparison can then be made by the electrosurgical system between the currently monitored parameter with a maximum value previously obtained associated with similar tissue. For example, a template may be used that stores a maximum value of similar tissue and/or pre-determined thresholds that can be compared with the currently monitored parameter. If the currently monitored parameter falls within a window or range (e.g., percentage of the maximum value), the electrosurgical system can determine that a double/repeat seal condition is present. Accordingly, the electrosurgical system can instruct the electrosurgical generator to modify the RF energy being delivered to the tissue based on the identified double/repeat seal condition (in 74). For example, since the tissue was previously sealed, a lesser amount of RF energy may instead be used to vaporize fluid/water from the tissue. Furthermore, the electrosurgical generator can also be instructed to move onto the next stage/step (e.g., 75) of the sealing cycle thereby limiting the amount of RF energy being provided to the tissue.
Once the electrosurgical system identifies the RF output peak condition (73) or identifies that a double/repeated seal condition is present (74), the electrosurgical system can modify the RF energy being provided to the tissue (in 75). In particular, the electrosurgical generator will aim to provide RF energy that can be used to continue/maintain the vaporization of the fluid/water from the tissue at a constant rate. As an example, the electrosurgical generator can adjust the voltage profile of the RF energy in order to implement a gradual voltage ramp (75). In this example, the electrosurgical system can instruct the electrosurgical generator to cause the RF energy to ramp gradually increasing from a predefined initial value (e.g., 35 V) to a maximum value (e.g., 45V) over a predefined time period (e.g., 500 ms). It should be noted that the predefined initial value is less than the maximum value measured for the tissue undergoing the sealing process (or similar tissue that previously underwent the sealing process) in order to minimize the possibility of overheating the tissue.
During the modification of the RF energy (in 75), the electrosurgical system can monitor for a hold condition (76). For example, as the electrosurgical generator gradually ramps the voltage for the RF energy, the electrosurgical system can monitor for a hold condition (in 76) to indicate when the ramping of the voltage should stop. The electrosurgical system, in various embodiments, may be configured to measure, calculate, and/or monitor various parameters (e.g., phase, voltage, current, power and/or change/rate thereof) associated with the supplied RF energy and the tissue undergoing the sealing process. If the hold condition is met (e.g., a measured phase and/or current reaches, exceeds, or falls below a predetermined threshold or static value), the RF energy currently being provided to the tissue can be maintained by the electrosurgical generator at its current state. For example, if the electrosurgical system measures a phase that reaches or falls below a predetermined threshold value and measures a current that reaches or falls below a predetermined threshold value, the electrosurgical generator can be instructed that a hold condition is met. Once the hold condition is identified, the electrosurgical generator can be instructed to adjust the gradual voltage ramp of the RF energy to instead maintain a current voltage value (i.e. hold constant) (77). However, if the measured phase and current has not reached or crossed the predetermined threshold value, the electrosurgical generator can then be instructed to wait a predefined time period while continuing to supply the RF energy in the gradual ramping fashion (in 75) all while still monitoring for the hold condition (in 76).
Once the electrosurgical generator is instructed to hold the RF energy constant (in 77), the electrosurgical system can be configured to monitor for and identify when an end condition (78) has been satisfied. When the end condition is detected, the electrosurgical system will determine that the sealing cycle has been completed to the current tissue being sealed. For example, some end conditions may correspond to a pre-determined period of time that lapses after the hold condition (in 77) has been detected by the electrosurgical system. Other end conditions may be met when one or more parameters (e.g. current, power, voltage, phase) are measured by the electrosurgical system as reaching, exceeding, or falling below pre-determined thresholds. In any case, once the end condition has been determined to have been satisfied by the electrosurgical system, the electrosurgical system can initiate termination procedures that will end the sealing process being performed on the tissue. The termination instructions carried out by the electrosurgical system may include terminating/stopping the supply of RF energy that was being generated by the electrosurgical generator to the tissue (79).
It may be possible, prior to the start of the sealing cycle (e.g., before 71), that the electrosurgical system can be configured to measure an impedance at the electrosurgical instrument to determine whether an electrical short or open circuit condition is detected. Such determination can be performed by the electrosurgical system using a low voltage measurement signal delivered from the electrosurgical generator to the connected electrosurgical instrument. The measured impedance can be used by the electrosurgical system to determine if the tissue grasped by the electrosurgical instrument is within the operating range (e.g., 2-2000) thereby indicating that a sufficient amount (e.g., volume) of the tissue is grasped. If this initial impedance check is passed, the electrosurgical generator can be instructed to begin supplying RF energy to the electrosurgical instrument. However, if the initial impedance check fails, the electrosurgical system can output an error signal and inform the user (e.g., surgeon). In this way, the user can be informed to re-adjust the electrosurgical instrument to grasp a larger amount (e.g., volume) of the tissue. Once the RF energy is being supplied to the electrosurgical instrument (71) from the electrosurgical generator, the impedance/resistance need not be measured again.
While the above generally describe the electrosurgical system and how the electrosurgical system can be implemented with the sealing process of tissue, there are various scenarios that may also need to be considered when using the electrosurgical system with tissues having different characteristics such as different types, thickness, and/or condition (e.g., double/repeat seal). The following sections of the disclosure will describe the details and processes that can be considered and implemented by the electrosurgical system to more accurately identify the type, thickness, and/or condition of the tissue being sealed. Based on the identification, the RF energy can be better adjusted by the electrosurgical system to perform the sealing process on different tissues.
One detail that the electrosurgical system may need to identify to properly carry out the sealing process is the thickness of the tissue being sealed. The thickness of the tissue can influence the amount of RF energy needed to perform the sealing process. Furthermore, the thickness of tissue can also influence other parameters (e.g., voltage profile, current) of the RF energy being applied to the tissue. In an example, thick tissue (such as muscle and fat) tend to draw less current than thinner tissue (such as mesocolon or mesentery). Therefore, the sealing cycle for thicker tissue may tend to take longer to complete than thinner tissue. Furthermore, the amount of RF energy during the sealing cycle needed by the thicker tissue may also be greater than thinner tissue as there may be more fluid/water to vaporize in the former thicker tissue. Therefore, providing a way for the electrosurgical system to identify the tissue thickness early in the sealing process can allow for better configuration of the electrosurgical system such that an optimal amount of RF energy can be used to carry out the sealing process.
In each example, the electrosurgical system (e.g., electrosurgical generator) supplies RF energy that will be used to seal or fuse tissue (of varying thicknesses) via the electrosurgical instrument. The electrosurgical system is configured to control/modify the RF energy being supplied by the electrosurgical generator to the electrosurgical instrument. On one hand, the electrosurgical system needs to provide enough RF energy to the electrosurgical instrument so the electrosurgical instrument can properly heat the tissue to vaporize the fluid/water in the tissue and subsequently maintain the appropriate temperature adequate to complete the seal. However, the electrosurgical system also needs to ensure that the tissue is not exposed to excess amounts of RF energy to minimize or prevent damage to the tissue undergoing the sealing process.
The electrosurgical system implement a similar/same initial stage of the RF energy having a quickly increasing voltage (400) for a seal cycle regardless of the type of tissue being sealed. The quickly increasing voltage (400) corresponds to the RF energy having a voltage that increases over a minimal time period thereby resulting in a steep voltage slope (or rate of change). A measured maximum voltage level (410) can be used to identify when the tissue being sealed is heated to a sufficient temperature for initiating desiccation (e.g., fluid/water vaporization in the tissue). The aim of the initial stage of the seal cycle (associated with the steep voltage ramp) is to have the tissue heated to the temperature that corresponds to when desiccation can occur as quickly as possible. In some embodiments, the electrosurgical system implementing the initial voltage ramp (also referred to as voltage pulse) may customize the duration. For example, the electrosurgical system may have the duration of the initial voltage ramp be based on the type of tissue in contact with the electrosurgical instrument, rather than be or based on a static, fixed, or predefined value.
By identifying how long the maximum voltage level (410) will be applied to the tissue, the electrosurgical system can tailor the subsequent voltage profile (420, 430, 440) accordingly based on the tissue (e.g., thickness) being sealed to ensure that the vaporization for the tissue can continue at a controlled rate. Failure by the electrosurgical system to identify when vaporization begins can result in longer seal cycles as well as weaker burst pressures, more thermal spread and/or tissue adhesion because less than optimal amount of RF energy will be used. For example, if adjustments are made by the electrosurgical system to the voltage profile of the RF energy (corresponding to 420-440) too early before vaporization actually begins, the tissue may not have been heated to a temperature that would be appropriate to remove fluid/water from the tissue. Subsequent applications of RF energy will still be used for heating the tissue rather than being used mainly for removing fluid/water thereby resulting in some fluid/water that would remain in the tissue when the sealing cycle is terminated (e.g., timing condition). On the other hand, if adjustments by the electrosurgical system are made to the voltage profile of the RF energy (corresponding to 420-440) too late after vaporization begins, the tissue may be exposed to still increasing or high amounts of RF energy. The overexposure of RF energy to the tissue may overheat and damage the tissue thereby negatively impacting the tissue and the seal quality.
As illustrated in the figure, the application of the maximum voltage for the RF energy can vary in duration based on thickness of the tissue. Thinner tissues may reach the vaporization point faster than thicker tissue (e.g., thinner tissue may have less to heat up as well as less fluid/water to remove) thereby requiring a lesser duration of the maximum voltage. By comparing tissues that reach the same/similar vaporization point at the same time, the electrosurgical system can determine that these tissues have similar thicknesses.
Alternatively, identifying tissue having similar thicknesses can also be determined by the electrosurgical system based on calculating a ratio that compares a total time it takes the tissue to reach a temperature where vaporization begins and a measured current value at that point in time. Accordingly, thinner tissues will have a lower ratio value while thicker tissue will have a higher ratio value. These ratios can be stored in memory (e.g., template) so that the electrosurgical system can, for example, provide the appropriate voltage profile for the RF energy to the tissue being sealed based on what was provided to past tissue having a similar ratio.
In an embodiment, the electrosurgical system can store (within the memory module or any other data storage device) instructions identifying how the RF energy may need to be identified based on different characteristics associated with the tissue being sealed. For example, tissue having a first thickness may need to be provided a particular voltage profile while a different tissue having a second different thickness may need to be provided a different voltage profile. The relationships between different tissue types, thickness, and/or conditions (e.g., repeat seals) and corresponding instructions that the electrosurgical system can execute (e.g., alter/modify RF energy, terminate RF energy) can be stored as a template and utilized by the electrosurgical system as needed. The template can be customized and updated by any number of different entities such as the manufacturer (of the electrosurgical generator and/or the electrosurgical instrument), the user (e.g., surgeon), or some other party (e.g., administrator). The template for the electrosurgical system can be downloaded on a separate computing device, transferred to the electrosurgical system via, for example, external memory device (USB), and stored in the memory module.
In some cases, the template can be stored in the electrosurgical instrument (e.g., via a memory module). Different electrosurgical instruments may interact with tissue and/or operate differently from other electrosurgical instruments (e.g., electrode size and electrode contact relative to the tissue). Therefore, data (e.g., operational instructions, templates) that can be used by the electrosurgical system to specially configure the operation of the electrosurgical system to be compatible with the specific electrosurgical instrument may also be useful. When the electrosurgical instrument is connected to the electrosurgical generator, the template associated with the electrosurgical instrument can then be provided and stored at the electrosurgical generator for use immediately as well as in subsequent future operations.
Other possible reasons for the difference in the implementation of the maximum voltage may also be based on the type of tissue undergoing sealing and/or the amount (i.e., volume) of tissue grasped by the electrosurgical instrument being sealed. As with thickness, other templates can also be provided to the electrosurgical system that categorizes other types of tissues (e.g., fat, muscle) so that electrosurgical system can utilize in providing the appropriate RF energy once the type of tissue has been identified.
With the electrosurgical system aiming to obtain the RF output peak condition for each of the different types of tissue being sealed, the amount of time the electrosurgical system (or specifically the electrosurgical generator) can then supply the RF energy can be made to vary. For example, as illustrated in
Generally, RF output peak condition occurs later in the seal cycle for thicker tissue because thicker tissues take longer to heat up compared to thinner tissue. As an example,
Independent of the volume and/or thickness of the tissue undergoing the seal cycle, the amount of time for sealing the tissue can be limited to a pre-determined maximum time threshold or limit. The pre-determined maximum time threshold or limit can be established as a means of minimizing or preventing situations where a user (e.g., surgeon) may apply RF energy to tissue for longer than necessary. The downside of setting the pre-determined maximum time threshold (e.g., static time period) without actually reaching the RF output peak condition could lead to scenarios where either the electrosurgical system applies RF energy longer than necessary (e.g., for small tissue volumes) or where the electrosurgical system does not apply enough RF energy (e.g., for large tissue volumes). Therefore, a dynamic voltage ramp can be implemented by the electrosurgical system to balance performance on each end (e.g., applying RF energy for too long and not applying RF energy long enough) by allowing for a close-to-ideal or optimal RF energy dosage. By having the electrosurgical system configured to rapidly achieve the RF output peak condition, the electrosurgical system can optimize overall sealing of tissue and reduce the time to seal the tissue without losing or reducing tissue integrity.
As described above, the electrosurgical system is configured to provide an initial high voltage ramp or pulse to bring the tissue to the RF output peak point quickly (as the RF output peak condition represents or corresponds to a water vaporization point or condition). The water vaporization point or condition occurs when the tissue temperature is highest and immediately prior to water vaporization occurring in the tissue. In an example sealing process, the electrosurgical system can instruct the electrosurgical generator to modify the voltage of the RF energy to be high (e.g., 40% or greater than a pre-determined maximum) with a quickly increasing rate of change (e.g., at a rate 10 volts per millisecond). The increase in voltage of the RF energy is performed to provide the dynamic voltage ramp or pulse used to achieve the RF output peak condition quickly.
The RF output peak condition can be observed visually by the user (e.g., surgeon) when steam starts being generated from the tissue being sealed. However, such visual observation can be unreliable. For example, if the RF output peak condition is not properly identified prior to moving on the seal cycle, the tissue can become under-pulsed. Specifically, if the vaporization or peak point is not reached during the initial voltage ramp or pulse (e.g., under-pulsing), then the subsequent drop in voltage and gradual ramp-up can slow down the vaporization of the fluid/water in the tissue as the seal cycle progresses. Tissue that is under-pulsed starts its effective seal cycle (e.g., removal of water) much later than anticipated thereby resulting in less total water being removed in the same time period. Therefore, properly and accurately identifying when the RF output peak condition occurs (e.g., desiccation begins) in tissue can be important.
By using a dynamic ramp methodology, the electrosurgical system can ensure that tissue (regardless of volume) can be brought to its optimal RF output peak condition point quickly before progressing further into the seal cycle. In doing so, the likelihood of under-pulsing (or not providing sufficient RF energy to have the tissue reach the RF output peak condition) is dramatically reduced. Furthermore, by reducing the likelihood of under-pulsing, the average RF delivery after the dynamic voltage ramp or pulse can be shortened in time or lowered in power without affecting seal quality. That is because once the RF output peak condition can be established, the focus or attention of the electrosurgical system can be directed to removing fluid/water from the tissue efficiently, rather than variability associated with heating tissue.
Determining by the electrosurgical system regarding when the RF output peak condition occurs can be difficult, particularly in real-time. A variety of factors (such as noise or similar fluctuations, imprecision in measurement of the RF energy output) may obscure or delay the determination of the RF output peak condition by the electrosurgical system. In some embodiments, the electrosurgical system can implement smoothing or filtering such imprecisions, which can assist in enhancing how the electrosurgical system can detect or determine the RF output peak condition. However, the delays associated with the electrosurgical system implementing filter processing and the like can delay the real-time determination of the RF output peak condition. One downside of delaying the real-time determination of the RF output peak condition is that the electrosurgical system could over-pulse (i.e., provide too much RF energy) the tissue.
To avoid or reduce the delay or a potential over-pulsing of the tissue, the electrosurgical system can utilize one or more state-based thresholds. The state-based thresholds can be used to identify different conditions or states during the sealing process based on a predicted maximum current value corresponding to the RF output peak condition. In an embodiment, the state-based thresholds can be a percentage of the predicted maximum measured current (e.g., 80% of the predicted maximum current value or window). In other embodiments, the state-based thresholds can be static offsets (e.g., 400 mA or 30 W below or within a predicted maximum value or window). In some embodiments, the state-based thresholds can incorporate a combination of both a percentage and a static offset based on the predicted measured maximum current.
In various embodiments, the state-based thresholds can be based on various parameters associated with the outputted RF energy such as current, voltage, power. However, for the purposes of this application, embodiments described herein will utilize current as the parameter (although the other parameters are also possible). The electrosurgical system will monitor the parameters associated with the outputted RF energy to detect when one or more of the state-based thresholds have been reached or crossed. By using the state-based thresholds, the electrosurgical system can determine when to move onto the next step/stage of the sealing process for the tissue.
In an example, state-based thresholds can be used to monitor when the vaporization of the fluid/water (i.e. desiccation) occurs in tissue. In one embodiment, once the maximum current value has been obtained, the electrosurgical system can calculate a percentage-based state-based threshold (e.g., 80%) using the maximum measured current that corresponds to when desiccation started. The state-based threshold used by the electrosurgical system can also be based on past collected data and correlation between the maximum measured current value and the maximum current value when desiccation generally occurs for other similar tissue. When the electrosurgical system detects that the measured current reaches and/or crossed the percentage-based state-based threshold, the electrosurgical system can make a determination regarding whether desiccation has occurred in the tissue. In this way, the electrosurgical system may determine not to move onto the next step of the sealing process (e.g., adjust the voltage level of the outputted RF energy) until this percentage-based state-based threshold has been reached. The electrosurgical system can use the state-based thresholds to ensure that desiccation has occurred by monitoring and detecting whether the measured parameter (e.g., current) reached or crossed the state-based threshold before the next step in the sealing process is performed (e.g., voltage is adjusted).
Accordingly, the lower (or greater offset) the state-based threshold is based on the maximum measured value, the longer the quickly increasing voltage of the RF energy output may need to be applied to the tissue. However, the increase duration of implementing the increasing voltage by the electrosurgical system may result in the possibility of over-pulsing the tissue. Accordingly, the electrosurgical system may be less likely to prematurely halt or drop the voltage of the RF output before desiccation has actually occurred (e.g., under-pulse) due to external factors such as noise.
The above describes an embodiment where a state-based threshold (based on maximum measured current value) is used to identify one of the steps/stages of the sealing process (e.g., the start of desiccation in the tissue). Other state-based thresholds can also be used to identify other steps/stages in the sealing process (e.g., when the output of RF energy should be terminated).
In various embodiments, the electrosurgical system may record or store a predicted maximum value (e.g., voltage, current) for use in calculating the state-based thresholds. However, to ensure that the recorded/stored value is an actual maximum value, the electrosurgical system can continue to monitor for subsequent measurements that exceed the stored predicted maximum value. In various embodiments, the electrosurgical system monitors or records parameters associated with the outputted RF energy at set intervals (e.g., every 50 ms) for a pre-determined period of time. During this time period, the electrosurgical system compares the recently monitored parameter against the stored maximum value to determine if a new maximum has occurred. When this occurs, the current monitored value is stored as the “new” maximum value. If no new maximum value is detected once the pre-determined period of time expired, the previous recorded maximum value is used.
As described above, the electrosurgical system can use the state-based thresholds to define when different steps/stages for the sealing process can occur. For example, the sealing process can be characterized by a series of different steps/stages with exit conditions (e.g., thresholds). As RF energy is applied and the value of interest changes (e.g., power, voltage, and/or current increases), the series of different steps or states are progressed through or cascaded. By increasing the number of states, the resolution of the cascade increases. However, depending on the resolution of the cascade, some accuracy can also be lost in determining the RF output peak condition. By using a cascade or similar progression of states or stages, the computational resources required from the electrosurgical system may be less intensive. Furthermore, the electrosurgical system may not require (or at least minimize) the use of the stored variables (e.g., measured maximum value) which also provides a way to reduce the computational resources required by the electrosurgical system in determining and managing the RF energy being applied to the tissue.
In accordance with various embodiments described herein, the electrosurgical system can utilize the state-based threshold (associated with a parameter such as voltage or current) that is calculated from a predicted or measured maximum value by multiplying the predicted value by a percentage (e.g., 80%). Higher predicted maximums may require a larger drop in the interested value (e.g., current or power) to trigger or to identify specific events (e.g., when desiccation has occurred). In some embodiments, the state-based threshold can be calculated by introducing a static offset value (e.g., −0.5V, 30 W, 400 mA). Depending on the predicted or measured maximum value, the static offsets can result in smaller or larger values than a percentage calculation. In any case, static offsets can be useful when the amplitude of noise or similar imprecision in the electrosurgical system are known because static offsets can be set to account for the specific imprecision (e.g., set higher than the amplitude of the noise). In various embodiments, the electrosurgical system utilizes a combination of both the static offset and percentage calculation acting in parallel, serially, and/or varying the order to enhance the identification or determination of the RF output peak condition and/or for calculation of state-based thresholds. Such combination of both static offsets and percentages may be useful in different situations to account for known imprecisions or when the predicted or measured maximum value reaches a specific threshold where a larger drop in the interested value to trigger a state-based threshold is not desired.
As the electrosurgical system monitors a rate of change of the interested value (e.g., current, voltage, and/or power), the electrosurgical system can then anticipate and detect the occurrence of the RF output peak condition. In addition, the electrosurgical system can also monitor and calculate the derivative or rate of change associated with the interested value. The derivative calculation is useful to identify whether the RF output peak condition is associated with a true peak or if the true peak is near or close to occurring subsequent a current detected peak (especially in situations where there are multiple peaks). As referred to herein, a true peak corresponds to the absolute maximum measured value for a parameter (e.g., current) obtained by the electrosurgical system during the sealing process—specifically during the initial voltage ramp. The true peak corresponds to the point during the seal cycle whereby the entirety of the tissue (especially in situations where the tissue being sealed has sections of varying thicknesses) is heated to a temperature sufficient to begin desiccation.
In various embodiments, the electrosurgical system is configured to adjust/modify parameters (e.g., current, voltage) of the RF output to determine whether a detected peak corresponds to the RF output peak condition. For example, the electrosurgical system (via instructions to the electrosurgical generator and/or RF amplifier) can gradually ramp up a parameter (e.g., current) associated with the RF energy being applied to tissue being sealed. The electrosurgical system can also place the electrosurgical generator into a state of current regulation. When a current regulation value exceeds the ability of the tissue being sealed in taking more current, the electrosurgical system may no longer be current regulated thereby resulting in a sharp increase in voltage as the electrosurgical system switches regulation. The sharp increase in voltage described above can be used as an indication or determination of the RF output peak condition. As such, the electrosurgical system can use this method or mechanism as another way to obtain a predicted maximum value based on a parameter of interest (e.g., current, voltage) that would correspond to the RF output peak condition.
In various embodiments, if an error or an unexpected result occurs, the electrosurgical system can terminate steps associated with the sealing process being performed (e.g., supplying RF energy to the tissue being sealed). In various embodiments, example errors detected by the electrosurgical system may include detection of an electrical short or an open circuit.
A detected electrical short circuit error can be determined by the electrosurgical generator when a measured phase angle of the supplied RF energy by the electrosurgical generator equals or exceeds a predetermined phase value (e.g., sixty degrees). A detected open circuit error can be determined by the electrosurgical generator when a measured current of the supplied RF energy equals or is below a predetermined value (e.g., 100 milliamps) and/or a measured voltage of the supplied RF energy equals or exceeds a predetermined value (e.g., 50 volts). The predetermined values for detecting the electrical short circuit and/or open circuit error can be customized based on various factors (e.g., type of electrosurgical device, area of the jaw).
If the electrosurgical system did not detect any error conditions during the sealing process, this can be used as an indication that the tissue was successfully sealed. A successful tissue seal, in accordance with various embodiments, is recognized as the tissue seal being able to withstand a predetermined range of burst pressures or a specific threshold pressure.
Returning back to the discussion regarding the sealing process, tissue seal formation may be dependent on denaturization and cross linkage of the native collagen present in vasculature extra cellular matrix (which may start at about 60° C.) of the tissue being sealed. Furthermore, the strength of the vasculature extra cellular matrix may be dependent on desiccation of the seal site (i.e., portion of the tissue undergoing the sealing process). As referred to herein, vaporization or removal of fluid/water present in the tissue undergoing sealing can also be referred to as desiccation. At temperatures of at least 80° C., the bonds between the denatured collagen and other living tissues can be created. However, collagen degrades in response to being exposed to elevated temperatures for an extended period of time rather than being exposed for a short period of time but having a peak temperature. As such, exposing tissue to high temperature conditions (e.g., 100° C.), for a short duration corresponding to a short seal cycle does not impact the structure of the collagen but still allows for vaporization of water/fluids within the tissue.
The total time needed to properly seal tissue may be based on how high and how fast the tissue is heated. In particular, the tissue may be exposed to high temperatures (e.g., 100° C.) in order to vaporize water/fluids within the tissue quickly so that the denatured collagen crosslinks and bonds to other living tissues. Furthermore, the quick vaporization of water/fluids is provided to limit situations where collagen-water hydrogen bonding can occur. To optimize seal time, an embodiment may aim to expose tissue to a temperature of 100° C. as quickly as possible in order to begin the desiccation process as soon as possible.
Referring back to
Applications of high voltage levels to tissue may cause the affected tissue undergoing the sealing process to adhere to the active electrodes on the jaws of the electrosurgical instrument. As such, termination of the gradual voltage ramp at a lower peak voltage and holding that voltage output constant 440 at the end allows for continued RF energy application for desiccation while reducing the possible occurrence of tissue adherence to the jaws/electrode of the electrosurgical instrument associated with applying too much voltage across the tissue. Determination by the electrosurgical system as to when to terminate the gradual voltage ramp may be conducted by monitoring various parameters associated with the RF energy being supplied (e.g., current, voltage, phase). For example, as tissue desiccates, the phase associated with the tissue may become more capacitive thereby drawing less current. By terminating the gradual voltage ramp at a fixed current value as the current falls and when the phase is capacitive, the desiccation level of the tissue can be categorized (i.e. a determination how much fluids/water has been removed from the tissue can be estimated). This allows for the electrosurgical system to better configure the seal cycle being carried out in order to provide the appropriate amount of RF energy based on, for example, electrical and structural differences in tissues being sealed. In other words, the electrosurgical system is capable of customizing how the seal cycle is performed for different types of tissues.
In various embodiments, state-based thresholds (e.g., percentage and/or static) based on the stored measured maximum value can also be used to identify when the gradual voltage ramp can be stopped, how long the RF energy should be held constant, and when the RF energy should be terminated. In order to achieve the appropriate tissue effect, the phase angle, current and/or power of the applied RF energy can be measured, calculated and/or monitored by the electrosurgical system.
As illustrated in
In an embodiment, the electrosurgical system determine when the RF output peak condition 121 is detected/reached. Once the RF output peak condition is detected (corresponding to the beginning of desiccation), the voltage of the RF energy is reduced and gradually ramped up relative to the initial voltage pulse performed during the initial period of time. The slow (or gradual) voltage ramp 132 by the electrosurgical system seeks to maintain the temperature of the tissue between the jaws close to 100° C. to control the boiling rate/vaporization of water/fluid in the tissue.
As the tissue undergoes desiccation, the electrosurgical system can monitor any number of different parameters of the RF energy (e.g., voltage, phase angle, current, and power) to determine when the voltage of the RF energy can then be held constant 133 (i.e., termination of the gradual voltage ramp 132). By recognizing the appropriate amount of RF energy to apply to the tissue for desiccation, the electrosurgical system can ensure that no more RF energy is applied to the tissue than what is needed to vaporize the water/fluids in the tissue. A benefit to controlling the amount of RF energy being applied to tissue in this manner is that there is a reduction in the possible tissue adherence between the tissue being sealed and the electrode/jaw of the electrosurgical instrument (which occurs when tissue is heated for longer than necessary).
Once the electrosurgical system detects that a seal cycle has been completed (whether the detection is based on waiting for a pre-determined time period or identifying that the corresponding state-based thresholds has been reached/crossed), the electrosurgical system can then terminate the RF energy supply being provided to the electrosurgical instrument used to seal the tissue. The termination of the RF energy supply generally refers to halting, disrupting, or stopping the supply of RF energy generated by the electrosurgical generator 134. In some embodiments, the electrosurgical system may automatically terminate the supply of the RF energy to the tissue after waiting a pre-defined period of time after the end of the previous gradual voltage ramp of RF energy 132.
To detect possible errors, the electrosurgical system can be configured to identify unintended current draw. As an example, some tissues may appear to draw the maximum current or power that can be supplied by the electrosurgical generator. While the electrosurgical system is under such a current condition, the supply of RF energy required to seal the tissue 1) may not be sufficient or 2) may not be efficiently supplied by the electrosurgical system. To handle such a condition, the electrosurgical system may be configured to determine if the current of the RF energy output is greater than a pre-determined threshold (e.g., 90% of the allowable maximum current or 4500 mA). If the detected current is equal or greater than the pre-determined threshold, the electrosurgical system may pause or incorporate a delay to ensure that the detected current has sufficiently dropped indicating that sufficient desiccation of the tissue has occurred. If, after the implemented pause or delay, the current has not sufficiently dropped, the electrosurgical system may raise an error and/or halt supplying the RF energy to the tissue. However, if the electrosurgical system detects that the current has sufficiently dropped below the pre-determined threshold (e.g., 4100 mA), a determination can be made by the electrosurgical system that the current condition has ceased and/or the tissue has reached the RF output peak condition (e.g., achieved a point where vaporization has begun).
In some embodiments, the electrosurgical system is configured to identify or determine a desiccation level of tissue in contact with the electrosurgical instrument. Some ways the electrosurgical system detects the desiccation level involves the electrosurgical system employing low levels of current or power, employing high levels of impedance, employing low phase angles, employing low energy delivery, and/or detecting steam associated with water vaporization during the seal cycle. Once the desiccation level of the tissue has been identified, the electrosurgical system can modify the RF output accordingly, such as providing RF energy for a limited time period or modifying a voltage level if the tissue has been determined to be sufficiently desiccated. In various embodiments, static thresholds can be used for any of these values (e.g., current, power, impedance, phase angles) to trigger conditions (e.g., 500 mA). Alternatively, thresholds can also be based on percentage calculations based on a predicted maximum (e.g., 20% below a predicted maximum current).
In various embodiments, the electrosurgical system can also implement one or more of the state-based threshold values (associated with one or more of current, power, impedance, phase angles) to specifically distinguish situations where already-sealed tissue is present. The electrosurgical system can then be adapted to trigger early in the seal cycle and progress through to the later steps of the seal cycle. At the end of the seal cycle, first activations and subsequent activations can look very similar with the tissue being sufficiently desiccated in both cases. However, at the beginning of the seal cycle, first activations will draw much more current or power since water is still present in the tissue while subsequent seals will not draw as much current or power since the water has been previously removed (e.g., vaporized). In addition, as tissue undergo a first sealing cycle, the current or power drawn can change substantially. In contrast, subsequent activations on already-sealed tissue will have a much lower rate of change regarding current or power drawn.
In various embodiments, the electrosurgical system may be configured to track a phase of the RF output (e.g., at the beginning of a seal cycle) to identify/detect situations where the tissue has undergone repetitive seals and/or detect if the tissue is thin. For example, tissue that has undergone double seals tend to have phase values of greater than 20 degrees. Once a repeated seal or piece of thin tissue is identified, an alternate RF energy output (e.g., voltage profile) for sealing that tissue can be provided that is better adapted for that previously sealed or thin tissue.
In various embodiments, the electrosurgical system uses a cascade of phase values which adjusts the RF output depending on the magnitude of the initial phase. For example, if the measured phase is between 20 and 25 degrees, the electrosurgical system can apply a modest reduction of RF energy. However, if the phase is between 25 and 30 degrees, the electrosurgical system may be able to determine with more certainty the type or condition of the tissue in contact with the electrosurgical instrument and thus reduce further (or more aggressively) the RF energy. A detected phase angle over 30 degrees would have the electrosurgical system provide the largest or most aggressive reduction in RF energy. It should be noted that other parameters (e.g., current) could be monitored to identify/detect the type of tissue and/or state of the tissue as well as adjust the RF energy being applied to tissue.
Once highly desiccated or thin tissue has been identified, any change in RF output that results in less heat being applied results in a better sealing effect for the tissue. In contrast, additional RF energy or no reduction in RF energy on highly desiccated or thin tissues can result in various negative outcomes such as additional thermal spread, eschar, adhesion, and/or a longer procedure time without providing further benefits to hemostasis.
Thus, in various embodiments, the electrosurgical system is configured to detect situations where double/repeat seals occur by using a threshold value or range of threshold values to detect repeat seal situations and/or to stop a voltage ramp. This method or mechanism may then provide a lower hold voltage through the sealing process, use a threshold value to terminate or halt RF output, and/or end the seal cycle earlier. In various embodiments, the electrosurgical system is also able to use a threshold value to immediately leave a state (e.g., current step in the sealing process) rather than reaching a timeout value (e.g., pre-determined period of time associated with the current step) that can reduce the total seal time for the tissue.
In various embodiments, the maximum current or power value can be static or predetermined. This maximum value can be stored in memory or provided/set through external inputs (e.g., user interface on the electrosurgical generator) to the electrosurgical system. In accordance with various embodiments, the maximum current or power value is determined by the electrosurgical system through the application of the RF energy and having the electrosurgical system monitor the current and/or power of the supplied RF energy to detect a peak condition associated with the monitored current or power. In various embodiments, the maximum current or power value represents a vaporization point (i.e., when desiccation starts) for the tissue in contact with the electrosurgical instrument. In various embodiments, the electrosurgical generator provides a steep ramping voltage profile in order to bring the temperature of the tissue to a water vaporization point quickly.
In accordance with various embodiments, a maximum phase value is determined by the electrosurgical system through the application of the RF energy and monitoring the phase to determine a peak condition associated with the monitored phase. In various embodiments, a temperature sensor or detection system (e.g., thermocouple) is provided with the electrosurgical instrument to monitor tissue temperature and potentially identify a rapid rise of temperature occurring until water vaporization begins. In some embodiments, the temperature sensor or detection system (e.g., thermocouple) can be embedded on the surface of a jaw associated with the electrosurgical instrument. Once the point of water vaporization beginning has been detected, the electrosurgical system can implement a state change that would stop the rise in temperature. As noted above, the point of water vaporization can correspond to an RF output peak condition.
In accordance with various embodiments, a minimum impedance can be determined by the electrosurgical system through the application of the RF energy and monitoring the tissue impedance to determine an impedance floor representing an RF output peak floor. As such, the thresholds for detecting different conditions associated with the sealing process by the electrosurgical system may appear inverted with a minimum value or window being determined rather than a maximum (as in the case with current, power, or phase described above).
In accordance with various embodiments, the electrosurgical generator can be configured to provide additional regulation of various parameters or functions related to the output of the RF energy (e.g., voltage, current, power and/or phase). The electrosurgical generator can also configure the operations engine to utilize the various parameters or functions to adjust the output of RF energy being provided to the electrosurgical instrument accordingly. In one exemplary embodiment, the control circuitry of the electrosurgical generator provides additional regulation controls for direct regulation of phase in which voltage, current and/or power output would be adjusted to satisfy specified phase regulation set points provided by the operations engine.
In accordance with various embodiments, the electrosurgical generator also utilizes the monitored, measured and/or calculated values (e.g., voltage, power, current and/or phase) as control indicators in order to recognize a current state of the tissue and identify what needs to be executed next for the sealing process (e.g., adjusting the amount of RF energy being applied to the tissue). In various embodiments, additional measurements or calculations based on the measured values related to RF output regulation circuitry are provided via a script or an operations engine that can be used to recognize and act upon additional or different events related to or triggered by the additional measurements or calculations. The additional measurements described above may include error signals in combination with a pulse width modulation (PWM) duty cycle that is used to regulate various RF energy output parameters (e.g., voltage, current and/or power). Different or additional events or indicators that could be identified and triggered in various embodiments could be used as transitions from one regulation control to another regulation control (e.g. changing from current regulation to power regulation).
In various embodiments, the electrosurgical generator can be configured to utilize many states, control points, feedback, or checks to identify a current parameter value (e.g., phase, current, or power) and whether the parameter value has a positive or negative trend. An error can be signaled if the electrosurgical generator does not identify an expected trend. The use of the multiple states, control points, feedback and checks increase or enhance the resolution associated with the electrosurgical generator in identifying an expected RF output trend over different types of tissue.
In various embodiments, the electrosurgical generator can also monitor the phase or current and/or rate of change associated with the phase or current to determine if there is an electrical open or short condition associated with the connected electrosurgical instrument. In one example, the electrosurgical generator identifies an electrical short condition of the connected electrosurgical instrument by monitoring the phase of the outputted RF energy. If the monitored phase is greater than a predefined maximum phase value, the electrosurgical generator can confirm that the electrical short condition is present. Similarly, the electrosurgical generator can also identify whether an electrical open condition is present in the connected electrosurgical instrument by monitoring the current of the outputted RF energy. If the monitored current is less than a predefined minimum current, the electrosurgical generator can confirm that an electrical open condition is present. For both scenarios, the detection of the short or open condition causes the electrosurgical generator to flag that an error is present. Furthermore, the electrosurgical generator can terminate/halt the RF energy being supplied to the connected electrosurgical instrument.
In various embodiments, the process associated with the electrosurgical system (as described throughout the application) may be loaded into a memory module embedded into a connector and, in one embodiment, is removably connected to a plug and/or cable connection associated with the electrosurgical instrument. In various embodiments, a device script or process is programmed onto an adapter PCBA contained within the device connector or hardwired into circuitry within the device connector or controller during manufacture/assembly. The script source file can be written in a custom text-based language and then compiled by a script compiler into a script database file that is only readable by the electrosurgical generator. The script file contains parameters specifically chosen to configure the electrosurgical generator to output a specific voltage (e.g., 100 v (RMS)), current (e.g., 5000 mA (RMS)), and/or power level (e.g., 300 VA). In various embodiments, a device key programmer device reads and then programs the script database file into the memory of the adapter PCBA.
As described throughout the application, the electrosurgical generator can be configured to supply RF energy to a connected electrosurgical instrument. The electrosurgical system ensures that the supplied RF energy from the electrosurgical generator does not exceed specified parameters via detection of faults or error conditions. In various embodiments, the electrosurgical instrument provides the commands or logic used to appropriately apply RF energy, for example, based on a surgical procedure and/or tissue type. The electrosurgical instrument may include memory having commands and parameters that dictate the operation of the electrosurgical instrument and/or electrosurgical generator. For example, in an embodiment, the electrosurgical generator can supply the RF energy but the connected electrosurgical instrument decides how much or how long the RF energy should be applied to the tissue. The electrosurgical generator may not allow the supply of RF energy to exceed a set threshold even if directed to by the connected electrosurgical instrument thereby providing a check or assurance against a faulty instrument command.
The above sections described different steps tied to the sealing process performed by the electrosurgical system. Specifically, the identification of the RF peak output condition is an important step in order to allow the electrosurgical system to manage the RF energy being supplied to the tissue. As described above, the RF peak output condition corresponds to the initial voltage ramp used to heat the tissue to a temperature where desiccation begins. The following embodiments are directed towards additional features that may be incorporated with or otherwise included with the electrosurgical system to better identify characteristics (e.g., type, thickness, condition) about the tissue undergoing the sealing process to address the possible issues with identifying the RF peak output condition. In this way, the electrosurgical system can also be configured to better and/or more efficiently calculate how much RF energy to provide to the tissue undergoing the sealing process and subsequently modify the generated RF energy accordingly in real-time.
A. Identifying Tissue
The identification of the type of tissue (as well as the current state of the tissue) can be useful for the electrosurgical system in managing the sealing process. Based on the identification of the thickness of the tissue being sealed or whether the tissue was previously sealed (e.g., repeat sealed), the RF energy output can be modified such that an appropriate amount of RF energy is provided. For example, the electrosurgical system can provide more RF energy for thicker tissues as thicker tissues may require more energy to heat up for desiccation to begin or more energy to remove the requisite amount of fluid/water from the tissue. In contrast, tissues that have been previously sealed or are on the thinner side may be provided less RF energy as less energy may be needed to heat up the tissue or remove the fluid/water from the tissue.
a. % Max to Identify Repeat Seals
By using a measured maximum current value, the electrosurgical system can calculate a variety of different threshold values. These threshold values based on the measured maximum current values can be used by the electrosurgical system to correspond to different conditions related to the tissue undergoing the sealing process. One threshold that can be implemented may be used to identify whether the tissue previously underwent the sealing process (e.g., repeat seals).
Tissue that was previously sealed may have a significant amount of fluid/water removed in the prior sealing cycle. As such, if the previously sealed tissue was again exposed to the same high amounts of RF energy, the tissue can experience negative effects such as sticking, thermal spread and jaw heat. Therefore, there is a need for the electrosurgical system to identify repeat seal scenarios in order to minimize and reduce the amount of RF energy being applied to tissues that were previously sealed.
Generally, tissues that underwent sealing before have little remaining fluid/water content. Therefore, any fluid/water remaining in the tissues will vaporize quickly when the tissue undergoes the sealing process again. The speed by which the little remaining fluid or water content vaporizes in the previously sealed tissues can correspond to a sharp drop in current relative to a maximum current measured immediately prior with that tissue. This behavior for the measured current is much different compared to if RF energy is applied to tissue that was not previously sealed. Thus, by using a threshold (e.g., a low % of the maximum current) corresponding to this sharp drop in measured current from the maximum measured current, the electrosurgical system can be configured to detect and identify if and when a repeat seal condition is present (e.g., if the measured current reaches the low % threshold within a pre-determined period of time from when the maximum current was measured). Accordingly, the electrosurgical system can then modify the RF energy being delivered to the previously sealed tissue to be different, compared to if that same tissue was not previously sealed.
b. Identifying Tissue Thickness Based on Maximum Current
With a maximum current measurement, the electrosurgical system can determine information about tissue that can be used to manage the RF energy being used in the sealing process. In one embodiment, the electrosurgical system can calculate a thickness of the tissue being sealed based on information related to the maximum current measurement. An example illustration (see
Because different types of tissue can have different thicknesses, the electrosurgical system can be configured to identify the type of tissue being sealed based on the measured maximum current (and in turn the calculated thickness) and use that information to modify the RF energy subsequently used in the sealing process. For example, the thickness of arteries is different from the thickness of veins (presuming that each of the arteries and veins being sealed have similar diameters). Therefore, tissue thickness can be seen as corresponding to the conductivity of the tissue (i.e., conductivity is higher for thinner tissues). The following equation can be used to summarize this relationship:
Accordingly, the electrosurgical system can modify the amount and manner the RF energy is being generated by the electrosurgical generator in order to accommodate the thickness of the tissue being sealed.
Tissue thickness could also be identified by the electrosurgical system based on monitoring a time needed for the tissue undergoing the sealing process to reach the point where fluid or water content begins to vaporize. Generally, thicker tissues will take a longer time to reach the water vaporization point compared to thinner tissue (presuming similar area and conductivity) as thicker tissue may need more energy to heat up a larger amount of tissue to the appropriate temperature for vaporization. This relationship can be seen in
Tissue Thickness∝Water Vaporization Time
Since tissue thickness has correlations with both measured maximum current and water vaporization time, the combination of these two relationships could be used to better distinguish between different tissue thicknesses. The following equation for tissue thickness combines the two earlier relationships.
Furthermore,
Because data about both the water vaporization time and the maximum current for the tissue can be obtained early during the sealing process by the electrosurgical system, the electrosurgical system is thus able to calculate and determine the possible tissue thickness of the tissue being sealed using the measured water vaporization time and measured maximum current. In doing so, the electrosurgical system can subsequently modify the RF energy being generated by the electrosurgical generator so the amount or method of RF energy delivery to the tissue can be made to be based on the thickness of the tissue being sealed.
Finding out the thickness of the tissue can be useful in how the electrosurgical system can modify the amount and delivery of the RF energy during the sealing process. For example, the electrosurgical system can control the voltage ramp that defines the fluid/water vaporization rate and the temperature of the tissue after vaporization begins. The difference can be seen in
As illustrated in the figure, the beginning of the voltage ramp is the same for both different types of tissues (e.g., arteries and veins). The use of the initial voltage ramp is important because it is at this point the tissue (that presumably hasn't been previously sealed) still has all of its fluid/water content. Therefore, the electrosurgical system is configured to heat the tissue to a high enough temperature to begin vaporization of the fluid/water. However, as the fluid/water is vaporized, steam will be generated from the tissue. The electrosurgical system can monitor the rate at which the tissues are heated in order to detect situations where excessive steam generation can damage the seal being formed.
Once the appropriate temperature has been reached, the electrosurgical system can then modify the voltage of the RF energy to drop to a lower voltage amount and subsequently gradually rise the voltage level in order to maintain the temperature of the tissue (and in turn control the vaporization of the fluid/water in the tissue at a controlled rate). For thinner tissue with a lower ratio value, the electrosurgical system can use a lower voltage start value to lower the water vaporization rate. On the other hand, the electrosurgical system can retain a higher voltage start value for thicker tissue as more energy may be needed to heat the temperature of the tissue for the rate of water vaporization to be maintained. Another benefit of retaining a higher start value for thicker tissue may also be that a lower voltage may cause the temperature to drop too much for thicker tissue which interferes with the vaporization process that is already in progress.
As the tissue desiccates, the volume of the tissue may decrease thereby making it easier for the electrosurgical system to increase the temperature of the tissue. A continuous increase in voltage will eventually result in the tissue reaching high temperatures (e.g., 200-220° C.), which can damage the collagen structure of the seal, resulting in lower seal reliability. Therefore, stopping the gradual voltage ramp when the tissue temperature is within acceptable or pre-determined limits can be useful in optimizing the seal being produced on the tissue. Similar to the initial voltage ramp, the ratio value is used to set higher ramp endpoints for thicker tissue and lower ramp endpoints for thinner tissue.
The ratio value allows the electrosurgical system to adapt the RF energy output to be optimized for different types of tissues (e.g., tissues having different thicknesses). Without this identification and the ability to accurately modify the voltage profile of the RF energy, a single voltage profile would need to be used by an electrosurgical generator for all tissue types which results in some tissue either being heated too hot or not heated hot enough during the seal cycle.
Last,
On the other hand, thicker tissue with a higher ratio value may draw less current for the same level of desiccation (compared to thinner tissue). As such, thicker tissue may take longer to seal (depending on how the voltage is set). To account for the additional needed RF energy, the electrosurgical system may set the endpoints for the seal-cycle at lower % thresholds (in relation to the maximum current) or later in the seal cycle.
B. Identifying Maximum Current Peaks
Predicting and/or identifying when the RF output peak condition (e.g., maximum current) has occurred for different tissues can be difficult. As noted above, the electrosurgical system can use the identification of the RF output peak condition for the tissue being sealed as an indicator that fluid/water vaporization has at least begun. Furthermore, once the RF output peak condition is detected, the electrosurgical system can be configured to modify an amount and/or delivery of the RF energy to the tissue in order to minimize or prevent damage to the tissue caused by overexposure of high amounts of RF energy.
However, there may be situations where the RF output peak condition (e.g., maximum current) is not obvious to the electrosurgical system. For example, there may be multiple measured current peaks detected by the electrosurgical system within a period of time. These current peak values can be caused by a variety of different factors such as noise, fluids still existing in the tissue, or having multiple different types and/or thicknesses of tissues being sealed using the same electrosurgical instrument. Furthermore, situations where a true RF output peak condition that is achieved much later in the seal cycle may be missed if the electrosurgical system instead chooses to erroneously use any number of prior maximum peaks as the maximum peak.
Use of an earlier (i.e., lower) maximum rather than the later (higher) maximum peak by the electrosurgical system may cause issues with the sealing process. Some problems may include not properly heating the tissue to the pre-determined temperature for vaporization of the fluid/water to being and failing to remove all the fluid/water from the tissue. Such issues may result in longer sealing times and/or incomplete seals.
To better identify situations where multiple peaks may be detected, the electrosurgical system may implement one or more features described as follows. First, the electrosurgical system can utilize an initial window that lasts for a pre-determined time period. This initial window can be seen in example graphical representations illustrated in
The pre-determined time period associated with the initial window can be pre-set or customized based on the surgical procedure or type of tissue being operated on. In some embodiments, the initial window will be set by the electrosurgical system to correspond to a pre-determined period of time when a maximum current value would not generally be expected to be detected based on, for example, the tissue being sealed or the electrosurgical instrument being used. If the electrosurgical system detects a maximum current value during the initial window, the electrosurgical system can be instructed to continue monitoring for a pre-determined amount of time for subsequent maximums. If no other maximums are detected once the pre-determined amount of time elapsed, the original detected maximum may then be used.
In one embodiment, as illustrated in
In a second embodiment, as illustrated in
Instead of just relying on the first maximum peak that is detected, the electrosurgical system can continue to monitor the measured current of the RF energy at the tissue until a later maximum current is detected. This later maximum current, since it is after the initial window, can be used to correspond to the RF maximum output condition and indicate that water vaporization for the tissue has begun. In this way, the electrosurgical system can better ensure that the tissue has been sufficiently heated and that fluid/water in the tissue has begun to vaporize. As described above, the electrosurgical system is configured to modify the RF energy being provided to the tissue based on the determination that vaporization for the fluid/water in the tissue has begun.
Although the initial window may generally correspond to a time period where vaporization is not expected to occur, it may also be possible for the electrosurgical system to decide that the maximum current detected during the initial window corresponds to the RF maximum output condition. For example, as illustrated in
C. Concavity Check
As noted above, vaporization of fluid/water in the tissue can be recognized by the electrosurgical system when the system detects an increase in current up until a maximum value and a subsequent drop in the measured current (e.g., down to a pre-determined threshold). However, the determination that the fluid/water of the tissue has begun to vaporize is based on an assumption that the tissue that is grasped by the electrosurgical instrument is a single circuit having a uniform state (e.g., type, thickness) in terms of electric field, compression, and/or temperature. Therefore, situations where multiple different types of tissues are all being sealed at the same time using the same electrosurgical instrument may pose challenges in properly identifying when the fluid/water of the different tissues have all begun to vaporize (e.g., scenario where portions of both veins and arteries are being grasped within the electrosurgical instrument). Relying on the first measured maximum current can result in only a portion of the tissue reaching the necessary temperatures to properly start the vaporization of the fluid/water. If the entirety of the tissue is not heated to the appropriate temperature needed to start the vaporization, subsequent removal of the fluid/water may not be efficiently carried out. As a result, the sealing time of the tissue may be extended or the resultant seal may be inconsistent or weak.
An example scenario is illustrated in
To determine whether a subsequent peak may be present, the electrosurgical system can perform calculations based on the speed in which the current measurement drops from the detected maximum for a pre-determined period of time. For example, if the drop in the measured current (detected by the electrosurgical system) slows down prior to flatlining and then increases, this behavior can be used by the electrosurgical system to indicate that a subsequent peak may be occurring if the heating of the tissue continues. If there is a possibility that a second peak can occur, the electrosurgical system may maintain the initial increase in voltage (i.e. initial voltage spike) to the tissue for the purposes of heating the tissue to the temperature sufficient for vaporizing fluid/water in the tissue. By having the electrosurgical system monitor for this pattern (e.g., drop, flatline, and rise in measured current), the electrosurgical system can make predictions as to when subsequent peaks may be possible. If subsequent peaks in current are anticipated, the electrosurgical system may or may be instructed to continue the initial voltage spike so that other portions of the tissue can be heated.
To determine whether subsequent peaks are potentially occurring, the electrosurgical system can be configured to calculate second derivatives of the measured current and compare the output to the concavity of the rate of change of the current.
Detecting and measuring concavity of the measured current via the electrosurgical system can have various challenges. For example, derivatives have more inherent noise than their parent signals. Furthermore, the events that are detected by the electrosurgical system using the derivatives can occur within short time intervals (e.g., 5-50 ms) which may be difficult to identify and distinguish with the noise. To account for the noise, in one embodiment, is by implementing an approximation of the second derivative by comparing the drop in the measured current over a time interval and the drop in the measured current over the previous time interval. Each time interval can be set to be relatively short (e.g., 4 ms). By having the electrosurgical system compare two adjacent time intervals and determine if the most recent drop is smaller than the previous drop, then the electrosurgical system can determine if the rate of change in the current is slowing down thereby indicating that the current is concave-up. In contrast, if the electrosurgical system detects that the most recent drop is equal to or greater than the previous drop, then the electrosurgical system can determine that the rate of change for the current may not to be concave-up.
By using the above approximation mechanism, the result of this computation by the electrosurgical system can then be stored as a variable. Generally, if the measured current is below the threshold value, the electrosurgical system can instruct the electrosurgical generator to end the initial voltage spike and move onto the next step/stage of the sealing process (e.g., dropping the voltage level down to a pre-determined threshold). However, with the concavity checks, the electrosurgical system makes additional checks to see if the initial voltage spike should be extended for a further period of time. If the variable (associated with the rate of change of the current) is zero (or linear) or negative (or concave-down), the electrosurgical system can terminate the initial voltage spike. However, if the variable is found to be positive (or concave-up), the initial voltage spike should not be ended at the current time. Instead, the electrosurgical system will maintain the initial voltage spike until a voltage termination condition is met (e.g., pre-determined time period), or a new next maximum is found. The concavity check cycle repeats & recalculates each time interval until the initial voltage spike is terminated.
Once fluid/water vaporization begins, the conductivity of tissue generally decreases. As such, it is not expected for the conductivity of the tissue to increase at any point as the RF energy is being applied to the tissue. Therefore, the electrosurgical system then tracks the measured current associated with the tissue in connection with various pre-determined thresholds (e.g., based on the maximum current). The pre-determined thresholds can be used to trigger an event with the electrosurgical system if a substantial increase in current (that is not expected) is detected. Triggering these pre-determined thresholds provides a way for the electrosurgical system to determine if the seal cycle is progressing in the opposite direction of what is expected. The triggering of these pre-determined thresholds informs the electrosurgical system that fluid/water vaporization in the tissue has not likely occurred in all parts of the tissue currently undergoing sealing.
Small and/or temporary increases may be allowed by the electrosurgical system in order to account for some tissue variability and/or noise. However, the pre-determined thresholds are generally a pre-determined percentage above the maximum peak of the measured current corresponding to when vaporization is detected. The percentages used by the electrosurgical system for the pre-determined thresholds can vary for various different situations. For example, the pre-determined thresholds can be set higher or lower based on how long the initial voltage spike has used or whether the pre-determined threshold has been previously triggered.
If the electrosurgical system detects that the pre-determined threshold has been crossed by the measured current, the electrosurgical system can enter a wait state which monitors for a maximum (i.e. peak) current followed by a drop. As noted above, detection of a maximum and drop in measured current can be used by the electrosurgical system to identify that fluid/water vaporization has begun in the tissue. If detected, the electrosurgical system can progress through the seal cycle to the next steps (e.g., after the voltage spike when desiccation begins in the tissue) which generally includes the voltage drop, gradual voltage ramp, and hold (as discussed above in steps 73-76 of
The wait state (with the monitoring of the current) allows the electrosurgical system the capability to continuously check for the state of fluid/water vaporization in the tissue. If the fluid/water vaporization (i.e., desiccation) has not started, the electrosurgical system can perform various soft-resets in the sealing process in order to ensure that the RF energy being applied to the tissue properly heats the tissue (in order to properly create a seal that is not only quick but effective).
The use of the pre-determined threshold (to check that fluid/water vaporization has begun in the tissue) by the electrosurgical system can extend the overall duration of the seal cycle, which may cause some tissue to have some negative reactions to the increase RF energy exposure such as thermal spread, sticking, and jaw heat. However, the implementation of the pre-determined thresholds by the electrosurgical system are also beneficial as the thresholds will further ensure that the entirety of the tissue being sealed has been heated to a proper temperature sufficient for desiccation.
Desiccation is highly desired for creating an optimal seal and can therefore be afforded a high priority. Without the pre-determined threshold, the electrosurgical system may not be able to detect whether additional heating time is needed. As such, the electrosurgical system may need to add additional heat (via extended RF energy exposure) to every seal in order to ensure that desiccation has begun to ensure an optimal seal is being created. By implementing the pre-determined thresholds, the electrosurgical system can check the status of the fluid/water vaporization occurring within the tissue. As such, the pre-determined thresholds allow for shorter seal times for most seals that progress through the seal cycle as intended (e.g., does not trigger the pre-determined threshold requiring extending the initial voltage spike), as only a minority of tissue seals will take advantage of the pre-determined threshold. In this way, the electrosurgical system can balance between creating optimal seal strengths while minimizing outcomes associated with overexposure of the RF energy to the tissue (e.g., thermal spread, sticking, jaw temperature).
In addition to configuring the electrosurgical system to determine whether the tissue is being properly heated so that fluid/water vaporization occurs throughout the tissue, the above feature of monitoring the measured current can also be used by the electrosurgical system for other purposes as well. For example, the electrosurgical system can also detect events, such as the addition of water or saline to the seal site (e.g., surgical irrigation or immersing the jaw into fluid) or short circuits. These events can slow or stop desiccation (or fluid/water vaporization) occurring at the tissue. In one embodiment, the electrosurgical system is placed into a wait state until the events (e.g., short circuit or immersion of the jaw in fluid) are no longer present.
D. Using % Max to Progress Through the Sealing Process
When tissue has a voltage applied to it, the conductivity of the tissue increases as the ions and fluid/water in the tissue heats up. When the temperature of the tissue rises high enough, vaporization of the fluid/water in the tissue begins. Steam coming from the tissue as well as the loss of fluid/water from the tissue decreases the conductivity of the tissue. Therefore, as water vaporization begins, the current stops increasing and instead starts decreasing. This corresponds to a measured “peak” or maximum current at a point in time with the tissue, which can be identified by the electrosurgical system.
Threshold values (based on the measured maximum current) can then be used to detect the magnitude of the current drop after the measured maximum. However, variations in the composition or geometry of the tissue, or the presence of electrical noise in the signal may result in the electrosurgical system detecting a local maximum and momentary drop prior to other peaks or maximums which may correspond to the true maximum (i.e. a maximum current that can be used to indicate that the entire tissue has been heated to a sufficient temperature for fluid/water vaporization). Thus to identify a true maximum, the electrosurgical system utilizes threshold values that may be set as high as possible, yet low enough to reliably detect the true water vaporization point. The threshold values may be carefully balanced to minimize “overpulsing” of the tissue (corresponding to an application of high voltage too long after water vaporization begins), while preventing “underpulsing” of the tissue (corresponding to not providing enough RF energy to the tissue such that the temperature of the tissue is not sufficient for desiccation) by dropping the voltage prior to water vaporization begins in all areas of the tissue.
a. Break Values
The threshold value used by the electrosurgical system can vary based on the properties of the tissue being sealed, as the tissue may have variations in composition or geometry. In addition, noise (such as being more likely at the beginning of the sealing process) and amplitude (e.g., A consistent 200 mA of noise has a better signal to noise ratio if the signal is 5 A compared to 3 A) can vary over time. In one scenario, a higher threshold value (such as 90% or 95% of the maximum current), as illustrated in
Furthermore, using the lower percentage based on the maximum value may result in a lower total drop. Because noise may become a larger percentage of the signal, more confidence is required to determine that the measured peak is the true maximum. Lower current draws indicate the tissue is more likely to be thicker. Particularly in the case of thicker tissue, it is possible, due to closure of the jaws, that certain parts of the tissue heat faster than other parts. Accordingly, the water vaporization point can occur at several different times for different areas of the tissue. Therefore, by having the electrosurgical system require to detect a larger drop in current via reducing the threshold value with a lower percentage (associated with the maximum current), is more likely to ensure that all portions of the tissue have reached the water vaporization point before ending the voltage spike.
In between a higher threshold (such as 90%-95%) and a lower threshold values (70%-85%), a sliding linear threshold value can used by the electrosurgical system as illustrated in
Continuing from the previous example, a possible scenario may have that the maximum current draw from arteries may generally be below 3000 mA but can rarely reach as high as 3600 mA. Furthermore, the maximum current draw from veins is generally above 4000 mA but the smallest veins can reach 3300 mA. Therefore, the linear break percentage between 3000 mA and 4000 mA allows for a compromise in the behavior of the algorithm, allowing the electrosurgical system to be optimized for both types of tissue (e.g., veins, arteries). Furthermore, the electrosurgical system can be more fully optimized in the range where there is generally no overlap of maximum current.
In addition to changing the break percentage based on the maximum current value, the break percentage used by the electrosurgical system can also be time-dependent. For a given type and amount of tissue, the time required for tissue to be heated to a temperature high enough for starting fluid/water vaporization may be consistent. The fluid/water vaporization time may be minimized for the smallest volumes of the highest conductivity tissue (such as 40 ms). Knowing this lower limit allows for the electrosurgical system to be configured to have a much more conservative break percentage (such as 50%) under this minimum expected fluid/water vaporization time. This allows the electrosurgical system to be less likely to end the initial voltage spike before the expected period of time for tissue to reach the temperature needed to begin fluid/water vaporization.
The use of the linear break also allows the measurements performed by the electrosurgical system to be more resistant to noise caused by small amounts of fluid on the jaws (as the fluid can boil very rapidly and much sooner than fluid/water in the tissue), which can create a false positive (or peak). The more conservative break percentage can be used by the electrosurgical system during the very beginning of the sealing cycle to ensure that the tissue being sealed has actually reached the fluid/water vaporization point. Furthermore, the more conservative break percentages can be implemented to require a higher level of confidence that the vaporization point has been reach before being able to end the initial voltage spike.
b. % Max to Identify Ramp Termination
The gradual voltage ramp may be used by the electrosurgical system to gradually increase the strength of the electric field in order to maintain a power output at the tissue as the conductivity of the tissue falls when fluid/water vaporization begins. The maintaining of the electric field by the electrosurgical system is to ensure that the fluid/water vaporization continues at a controlled rate. Generally, the electric field for a given voltage is inversely proportional to the thickness of the tissue. Therefore, in one embodiment, it may be desirable for the electrosurgical system to modify the voltage so that a higher voltage is provided for thicker tissue whereas thinner tissues may only need a lower amount of voltage.
As such, it may not be necessary for all tissue types to complete the entire voltage ramp during the gradual ramp state (e.g., step 75 of
By using a % threshold to identify when to terminate the gradual ramp, the electrosurgical system can set the maximum voltage that can be achieved during the gradual ramp stage of the seal cycle for each different type of tissue. For example, in situations where thicker tissues are present, the electrosurgical system can set a threshold that allows the tissues to achieve a higher voltage (via use of a higher % max threshold) which in turns allows for a higher power output and longer seal time (in order to ensure that the water/fluid has been properly vaporized from the tissue). On the other hand, for thinner tissues the electrosurgical system can set thresholds that allow a lower voltage to be achieved. With both these situations, the electrosurgical system can be configured to implement an optimal tissue temperature regulation based on the tissue being sealed.
c. % Max to Identify RF Done (Seal Cycle Completion)
Similar to terminating the initial voltage ramp using a % max threshold, the application of the RF energy for sealing the tissue can also be terminated by the electrosurgical system using a corresponding % max threshold. There may be situations where the electrosurgical system may determine that the application of the RF energy should be terminated sooner (e.g., for certain tissues which do not require additional time or heat to seal such as thin tissue or tissue that previously sealed). The electrosurgical system can detect when the application of RF energy could be terminated when there has been sufficient desiccation (which is indicated by the measured current associated with the tissue flatlining).
The identification of when the RF energy should be terminated can be detected by the electrosurgical system using a % max threshold value with respect to the maximum current recorded during the initial voltage spike state. Once this % max threshold value has been reached, the electrosurgical system can terminate the sealing cycle (via termination of the RF energy being provided to the tissue). Endpoints can vary greatly across tissue types as the current reacts differently based on the tissue thickness and surface area. Furthermore, seal times can also vary between vessel categories (e.g., arteries may need to undergo the sealing process longer than veins due to their thicker vessel wall). As such, the electrosurgical system can set conditions based on other information gathered about the tissue to better suit different tissue types in setting up when the RF energy should be terminated.
d. % Max to Identify Tip Seals
When small amounts of tissue are sealed at the tip of the electrosurgical instrument, the small surface area may lead to very low current draw (e.g., low maximum measured current). At the end of such a seal cycle, the current may fall low enough for the electrosurgical system to mistaken the measurement as corresponding to an open circuit. By using an appropriate % max threshold value with reference to the measured maximum current allows for a lower open condition threshold to be available for the electrosurgical system to identify this specific low current scenario. If the peak current is low (such as with a tip seal), the electrosurgical system can be adapted to recognize this situation and allow these smaller tissue bites to seal successfully without triggering an unnecessary alarm condition corresponding to an open circuit scenario.
e. % Max for Dynamic RF Shutoff/Termination
In further embodiments, the dynamic threshold value, which triggers the end of the seal cycle, can also be incremented at a certain rate (1%, 10%, 15%, etc.) during or after a predetermined interval in a user state. The increase in the dynamic threshold value can also allow larger tissues to desiccate fully while allowing fast cooking (i.e. thinner) tissues to exit the seal cycle when they reach an acceptable % max current.
In further embodiments, time-based thresholds can also be used by the electrosurgical system to determine when to shutoff/terminate the RF energy. For example, if the tissue was not initially heated to a high enough temperature for desiccation to begin, the electrosurgical system may expose the tissue to RF energy for a longer than expected period of time. The time-based thresholds (e.g., time-out) can be used by the electrosurgical system to determine when to terminate the RF energy once the sealing process has elapsed longer than a pre-determined period of time (e.g., associated with a maximum time that tissue should be exposed to RF energy). The time-based thresholds can also be used by the electrosurgical system to identify possible issues with the current sealing process and inform the user (e.g., surgeon).
E. Detecting Water Vaporization Based on Voltage/Impedance Relationship
For a static resistor, the impedance of a circuit does not change as a function of the RF energy being applied to it. Nor does the impedance change as a function of how much power is flowing through the circuit. Neither of these characteristics are true for tissue as tissue impedance is variable. As RF energy is applied to tissue, the impedance of the tissue initially drops with increased ion conductivity as the tissue heats. Afterwards, an increase in the impedance of the tissue follows as fluid/water vaporization begins. The increase in impedance is due to both desiccation occurring with respect to the tissue (e.g., changing the composition of the tissue from approximately saline to approximately plastic) and the presence of steam in the tissue (which has a high impedance). The impedance-related trend generally exists for most tissue when the tissue is being sealed with an electrosurgical system and lasts several seconds (e.g., 2.5 seconds).
In various embodiments, the electrosurgical system can use the relationship between tissue impedance and voltage to detect when water vaporization occurs. Example relationships between impedance and voltage can be seen in
The sharp changes in impedance due to changing voltage (i.e. the end of the voltage spike) can be used by the electrosurgical system to verify that fluid/water vaporization has begun in the tissue. If the voltage is dropped prior to fluid/water vaporization, the amount of steam in the tissue may already be zero and therefore, cannot decrease (e.g., there is no immediate change in the tissue impedance). However, if fluid/water vaporization began via the use of a high voltage and the voltage is dropped, the amount of steam will decrease thereby resulting in an impedance drop. The relationship between the impedance and voltage can then be used by the electrosurgical system as a verification that fluid/water vaporization has begun in the tissue (corresponding to when the initial voltage spike ends as the measured current begins to drop) which subsequently indicates that the electrosurgical system should drop the voltage. The voltage drop causes the impedance of the tissue to drop thereby slowing down the creation of the steam. However, if the fluid/water vaporization in the tissue has not begun, the tissue must be heated further to reach the water vaporization point.
As described generally above and described in further detail below, various electrosurgical instruments can be used in the electrosurgical systems described herein. For example, electrosurgical graspers, scissors, tweezers, probes, needles, and other instruments incorporating one, some, or all of the aspects discussed herein can provide various advantages in the electrosurgical system. Various electrosurgical instrument and electrosurgical generator embodiments and combinations thereof are discussed throughout the application. It is contemplated that one, some, or all of the features discussed generally throughout the application can be included in any of the embodiments of the instruments, generators and combinations thereof discussed herein. For example, it can be desirable that each of the electrosurgical instruments described include a memory for interaction with the generator as previously described and vice versa. However, in other embodiments, the instruments and/or generators described can be configured to interact with a standard bipolar radio frequency power source without interaction of an instrument memory. Further, although various embodiments may be described in terms of modules and/or blocks to facilitate description, such modules and/or blocks may be implemented by one or more hardware components (e.g., processors), Digital Signal Processors (DSPs), Programmable Logic Devices (PLDs), Application Specific Integrated Circuits (ASICs), circuits, registers and/or software components, e.g., programs, subroutines, logic and/or combinations of hardware and software components. Likewise, such software components may be interchanged with hardware components or a combination thereof and vice versa.
Further examples of the electrosurgical system, instruments, and connections there between and operations and/or functionalities thereof are also described in U.S. patent application Ser. No. 12/416,668, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,751, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,695, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,765, filed Apr. 1, 2009, entitled “Electrosurgical System”; Ser. No. 12/416,128, filed Mar. 31, 2009, entitled “Electrosurgical System”; and Ser. No. 14/848,116, filed Sep. 8, 2015, entitled “Electrosurgical System”; the entire disclosures of which are hereby incorporated by reference as if set in full herein. Certain aspects of these electrosurgical generators, instruments, and systems are also discussed herein, and additional details and examples with respect to various embodiments are described in US Provisional Application Nos. 61/994,215, filed May 16, 2014, entitled “Electrosurgical Fusion Device”; 61/944,185, filed May 16, 2014, “Electrosurgical Generator with Synchronous Detector”; 61/994,415, filed May 16, 2014, “Electrosurgical System”; and 61/944,192, filed May 16, 2014, entitled “Electrosurgical Generator”, the entire disclosures of which are hereby incorporated by reference as if set in full herein.
The above description is provided to enable any person skilled in the art to make and use the surgical devices and perform the methods described herein and sets forth the best modes contemplated by the inventors of carrying out their inventions. Various modifications, however, will remain apparent to those skilled in the art. It is contemplated that these modifications are within the scope of the present disclosure. Additionally, different embodiments or aspects of such embodiments may be shown in various figures and described throughout the specification. However, it should be noted that although shown or described separately each embodiment and aspects thereof may be combined with one or more of the other embodiments and aspects thereof unless expressly stated otherwise. It is merely for easing readability of the specification that each combination is not expressly set forth. Also, embodiments of the present invention should be considered in all respects as illustrative and not restrictive.
The following generally describes the subject matter that the present application covers:
An electrosurgical system for fusing or sealing tissue comprising:
Some of the features of the electrosurgical system described above comprise:
This application claims priority to and benefit of U.S. Provisional Patent Application Ser. No. 62/955,758 entitled “Electrosurgical System with Tissue and Maximum Current Identification” filed on Dec. 31, 2019 which is incorporated herein by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2073960 | Crosby | Mar 1937 | A |
| 2140593 | Pankonin | Dec 1938 | A |
| 2351608 | Greenwood | Jun 1944 | A |
| 2487565 | Leber et al. | Nov 1949 | A |
| 2641154 | Heller | Jun 1953 | A |
| 3076373 | Matthews | Feb 1963 | A |
| 3077812 | Dietrich | Feb 1963 | A |
| 3080564 | Strekopitov et al. | Mar 1963 | A |
| 3203220 | Kaepernik | Aug 1965 | A |
| 3252643 | Strekopitov et al. | May 1966 | A |
| 3273562 | Brown | Sep 1966 | A |
| 3373646 | Ehlert | Mar 1968 | A |
| 3459187 | Pallotta | Aug 1969 | A |
| 3494533 | Green et al. | Feb 1970 | A |
| 3662939 | Bryan | May 1972 | A |
| 3675688 | Bryan et al. | Jul 1972 | A |
| 3692224 | Astafiev et al. | Sep 1972 | A |
| 4261244 | Becht et al. | Apr 1981 | A |
| 4281785 | Brooks | Aug 1981 | A |
| 4304236 | Conta et al. | Dec 1981 | A |
| 4312363 | Rothfuss et al. | Jan 1982 | A |
| 4317451 | Cerwin et al. | Mar 1982 | A |
| 4407286 | Noiles et al. | Oct 1983 | A |
| 4434796 | Karapetian et al. | Mar 1984 | A |
| 4442964 | Becht | Apr 1984 | A |
| 4454875 | Pratt et al. | Jun 1984 | A |
| 4522327 | Korthoff et al. | Jun 1985 | A |
| 4527724 | Chow et al. | Jul 1985 | A |
| 4589582 | Bilotti | May 1986 | A |
| 4591085 | Di Giovanni | May 1986 | A |
| 4606344 | Di Giovanni | Aug 1986 | A |
| 4608981 | Rothfuss et al. | Sep 1986 | A |
| 4610383 | Rothfuss et al. | Sep 1986 | A |
| 4728020 | Green et al. | Mar 1988 | A |
| 4805823 | Rothfuss | Feb 1989 | A |
| 4892244 | Fox et al. | Jan 1990 | A |
| 4923350 | Hinksman et al. | May 1990 | A |
| 4941623 | Pruitt | Jul 1990 | A |
| 4955959 | Tompkins et al. | Sep 1990 | A |
| 4978049 | Green | Dec 1990 | A |
| 5031814 | Tompkins et al. | Jul 1991 | A |
| 5065929 | Schulze et al. | Nov 1991 | A |
| 5071052 | Rodak et al. | Dec 1991 | A |
| 5106008 | Tompkins et al. | Apr 1992 | A |
| 5116349 | Aranyi | May 1992 | A |
| 5129570 | Schulze et al. | Jul 1992 | A |
| 5180092 | Crainich | Jan 1993 | A |
| 5201746 | Shichman | Apr 1993 | A |
| 5221036 | Takase | Jun 1993 | A |
| 5236440 | Hlavacek | Aug 1993 | A |
| 5240163 | Stein et al. | Aug 1993 | A |
| RE34519 | Fox et al. | Jan 1994 | E |
| 5275323 | Schulze et al. | Jan 1994 | A |
| 5289963 | McGarry et al. | Mar 1994 | A |
| D347474 | Olson | May 1994 | S |
| 5307976 | Olson et al. | May 1994 | A |
| 5308576 | Green et al. | May 1994 | A |
| 5326013 | Green et al. | Jul 1994 | A |
| 5350400 | Esposito et al. | Sep 1994 | A |
| 5360305 | Kerrigan | Nov 1994 | A |
| 5364002 | Green et al. | Nov 1994 | A |
| 5366479 | McGarry et al. | Nov 1994 | A |
| 5381943 | Allen et al. | Jan 1995 | A |
| 5389098 | Tsuruta et al. | Feb 1995 | A |
| 5395034 | Allen et al. | Mar 1995 | A |
| 5397046 | Savage et al. | Mar 1995 | A |
| 5413267 | Solyntjes et al. | May 1995 | A |
| 5415334 | Williamson, IV et al. | May 1995 | A |
| 5415335 | Knodell, Jr. | May 1995 | A |
| 5439155 | Viola | Aug 1995 | A |
| 5439479 | Shichman et al. | Aug 1995 | A |
| 5445304 | Plyley et al. | Aug 1995 | A |
| 5447265 | Vidal et al. | Sep 1995 | A |
| 5452836 | Huitema et al. | Sep 1995 | A |
| 5456401 | Green et al. | Oct 1995 | A |
| 5458279 | Plyley | Oct 1995 | A |
| 5462215 | Viola et al. | Oct 1995 | A |
| 5464144 | Guy et al. | Nov 1995 | A |
| 5465895 | Knodel et al. | Nov 1995 | A |
| 5470006 | Rodak | Nov 1995 | A |
| 5470007 | Plyley et al. | Nov 1995 | A |
| 5470008 | Rodak | Nov 1995 | A |
| 5470009 | Rodak | Nov 1995 | A |
| 5472132 | Savage et al. | Dec 1995 | A |
| 5480089 | Blewett | Jan 1996 | A |
| 5485952 | Fontayne | Jan 1996 | A |
| 5487500 | Knodel et al. | Jan 1996 | A |
| 5489058 | Plyley | Feb 1996 | A |
| 5497933 | DeFonzo et al. | Mar 1996 | A |
| 5507426 | Young et al. | Apr 1996 | A |
| 5507773 | Huitema et al. | Apr 1996 | A |
| 5509596 | Green et al. | Apr 1996 | A |
| 5509920 | Phillips et al. | Apr 1996 | A |
| 5529235 | Boiarski et al. | Jun 1996 | A |
| 5547117 | Hamblin et al. | Aug 1996 | A |
| 5553765 | Knodel et al. | Sep 1996 | A |
| 5554164 | Wilson et al. | Sep 1996 | A |
| 5558266 | Green et al. | Sep 1996 | A |
| 5562241 | Knodel et al. | Oct 1996 | A |
| 5562700 | Huitema et al. | Oct 1996 | A |
| 5562701 | Huitema et al. | Oct 1996 | A |
| 5562702 | Huitema et al. | Oct 1996 | A |
| 5564615 | Bishop et al. | Oct 1996 | A |
| 5571115 | Nicholas | Nov 1996 | A |
| 5571285 | Chow et al. | Nov 1996 | A |
| 5579978 | Green et al. | Dec 1996 | A |
| 5580067 | Hamblin et al. | Dec 1996 | A |
| 5584425 | Savage et al. | Dec 1996 | A |
| 5586711 | Plyley et al. | Dec 1996 | A |
| 5588581 | Conlon et al. | Dec 1996 | A |
| 5597107 | Knodel et al. | Jan 1997 | A |
| 5601224 | Bishop et al. | Feb 1997 | A |
| 5605272 | Witt et al. | Feb 1997 | A |
| 5607095 | Smith et al. | Mar 1997 | A |
| 5615820 | Viola | Apr 1997 | A |
| 5626587 | Bishop et al. | May 1997 | A |
| 5630539 | Plyley et al. | May 1997 | A |
| 5634584 | Okorocha et al. | Jun 1997 | A |
| 5636779 | Palmer | Jun 1997 | A |
| 5657921 | Young et al. | Aug 1997 | A |
| 5662258 | Knodel et al. | Sep 1997 | A |
| 5662662 | Bishop et al. | Sep 1997 | A |
| 5662667 | Knodel | Sep 1997 | A |
| 5673840 | Schulze et al. | Oct 1997 | A |
| 5673841 | Schulze et al. | Oct 1997 | A |
| 5673842 | Bittner et al. | Oct 1997 | A |
| 5676674 | Bolanos et al. | Oct 1997 | A |
| 5678748 | Plyley | Oct 1997 | A |
| 5680982 | Schulze et al. | Oct 1997 | A |
| 5680983 | Plyley et al. | Oct 1997 | A |
| 5697542 | Knodel et al. | Dec 1997 | A |
| 5697543 | Burdorff | Dec 1997 | A |
| 5704534 | Huitema et al. | Jan 1998 | A |
| 5704898 | Kokish | Jan 1998 | A |
| 5706998 | Blyley et al. | Jan 1998 | A |
| 5709334 | Sorrentino et al. | Jan 1998 | A |
| 5713505 | Huitema | Feb 1998 | A |
| 5715988 | Palmer | Feb 1998 | A |
| 5718359 | Palmer et al. | Feb 1998 | A |
| 5732871 | Clark et al. | Mar 1998 | A |
| 5735445 | Vidal et al. | Apr 1998 | A |
| 5762255 | Chrisman et al. | Jun 1998 | A |
| 5762256 | Mastri et al. | Jun 1998 | A |
| 5779130 | Alesi et al. | Jul 1998 | A |
| 5782396 | Mastri et al. | Jul 1998 | A |
| 5782397 | Koukline | Jul 1998 | A |
| 5785232 | Vidal et al. | Jul 1998 | A |
| 5794834 | Hamblin et al. | Aug 1998 | A |
| 5797536 | Smith et al. | Aug 1998 | A |
| 5797537 | Oberlin et al. | Aug 1998 | A |
| 5797538 | Heaton et al. | Aug 1998 | A |
| 5810240 | Robertson | Sep 1998 | A |
| 5814055 | Knodel et al. | Sep 1998 | A |
| 5820009 | Melling et al. | Oct 1998 | A |
| 5829662 | Allen et al. | Nov 1998 | A |
| 5860995 | Berkelaar | Jan 1999 | A |
| 5865361 | Milliman et al. | Feb 1999 | A |
| 5878937 | Green et al. | Mar 1999 | A |
| 5878938 | Bittner et al. | Mar 1999 | A |
| 5893506 | Powell | Apr 1999 | A |
| 5894979 | Powell | Apr 1999 | A |
| 5901895 | Heaton et al. | May 1999 | A |
| 5918791 | Sorrentino et al. | Jul 1999 | A |
| 5931847 | Bittner et al. | Aug 1999 | A |
| 5954259 | Viola et al. | Sep 1999 | A |
| 5964394 | Robertson | Oct 1999 | A |
| D416089 | Barton et al. | Nov 1999 | S |
| 5988479 | Palmer | Nov 1999 | A |
| 6032849 | Mastri et al. | Mar 2000 | A |
| 6053390 | Green et al. | Apr 2000 | A |
| 6079606 | Milliman et al. | Jun 2000 | A |
| 6109500 | Alli et al. | Aug 2000 | A |
| 6131789 | Schulze et al. | Oct 2000 | A |
| 6155473 | Tompkins et al. | Dec 2000 | A |
| D441865 | Racenet et al. | May 2001 | S |
| 6241139 | Milliman et al. | Jun 2001 | B1 |
| 6250532 | Green et al. | Jun 2001 | B1 |
| 6264087 | Whitman | Jul 2001 | B1 |
| 6270453 | Sakai | Aug 2001 | B1 |
| 6325810 | Hamilton et al. | Dec 2001 | B1 |
| 6330965 | Milliman et al. | Dec 2001 | B1 |
| 6488196 | Fenton, Jr. | Dec 2002 | B1 |
| 6550757 | Sesek | Apr 2003 | B2 |
| 6569171 | DeGuillebon et al. | May 2003 | B2 |
| 6595509 | Sesek | Jul 2003 | B2 |
| 6619529 | Green et al. | Sep 2003 | B2 |
| 6644532 | Green et al. | Nov 2003 | B2 |
| 6669073 | Milliman et al. | Dec 2003 | B2 |
| 6716233 | Whitman | Apr 2004 | B1 |
| 6786382 | Hoffman | Sep 2004 | B1 |
| 6817508 | Racenet et al. | Nov 2004 | B1 |
| 6821282 | Perry et al. | Nov 2004 | B2 |
| 6835199 | McGuckin, Jr. et al. | Dec 2004 | B2 |
| 6913181 | Mochizuki et al. | Jul 2005 | B2 |
| 6923360 | Sesek et al. | Aug 2005 | B2 |
| 6953138 | Dworak et al. | Oct 2005 | B1 |
| 6953139 | Milliman et al. | Oct 2005 | B2 |
| 6964363 | Wales et al. | Nov 2005 | B2 |
| 6978921 | Shelton, IV et al. | Dec 2005 | B2 |
| 6986451 | Mastri et al. | Jan 2006 | B1 |
| 6988649 | Shelton, IV et al. | Jan 2006 | B2 |
| 7000818 | Shelton, IV et al. | Feb 2006 | B2 |
| 7044352 | Shelton, IV et al. | May 2006 | B2 |
| 7044353 | Mastri et al. | May 2006 | B2 |
| 7044947 | de la Torre et al. | May 2006 | B2 |
| 7055730 | Ehrenfels et al. | Jun 2006 | B2 |
| 7070083 | Jankowski | Jul 2006 | B2 |
| 7097089 | Marczyk | Aug 2006 | B2 |
| 7097650 | Weller et al. | Aug 2006 | B2 |
| 7108472 | Norris et al. | Sep 2006 | B2 |
| 7128253 | Mastri et al. | Oct 2006 | B2 |
| 7140527 | Ehrenfels et al. | Nov 2006 | B2 |
| 7140528 | Shelton, IV | Nov 2006 | B2 |
| 7143923 | Shelton, IV et al. | Dec 2006 | B2 |
| 7143924 | Scirica et al. | Dec 2006 | B2 |
| 7147139 | Schwemberger et al. | Dec 2006 | B2 |
| 7213736 | Wales et al. | May 2007 | B2 |
| 7225964 | Mastri et al. | Jun 2007 | B2 |
| 7237708 | Guy et al. | Jul 2007 | B1 |
| 7258262 | Mastri et al. | Aug 2007 | B2 |
| 7275674 | Racenet et al. | Oct 2007 | B2 |
| 7278562 | Mastri et al. | Oct 2007 | B2 |
| 7290692 | Marks | Nov 2007 | B2 |
| 7293685 | Ehrenfels et al. | Nov 2007 | B2 |
| 7303107 | Milliman et al. | Dec 2007 | B2 |
| 7308998 | Mastri et al. | Dec 2007 | B2 |
| 7328828 | Ortiz et al. | Feb 2008 | B2 |
| 7334717 | Rethy et al. | Feb 2008 | B2 |
| 7380695 | Doll et al. | Jun 2008 | B2 |
| 7380696 | Shelton, IV et al. | Jun 2008 | B2 |
| 7398908 | Holsten et al. | Jul 2008 | B2 |
| 7399310 | Edoga et al. | Jul 2008 | B2 |
| 7401721 | Holsten et al. | Jul 2008 | B2 |
| 7404508 | Smith et al. | Jul 2008 | B2 |
| 7407075 | Holsten et al. | Aug 2008 | B2 |
| 7407078 | Shelton, IV et al. | Aug 2008 | B2 |
| 7416101 | Shelton, IV et al. | Aug 2008 | B2 |
| RE40514 | Mastri et al. | Sep 2008 | E |
| 7419080 | Smith et al. | Sep 2008 | B2 |
| 7419081 | Ehrenfels et al. | Sep 2008 | B2 |
| 7422136 | Marczyk | Sep 2008 | B1 |
| 7422139 | Shelton, IV et al. | Sep 2008 | B2 |
| 7431188 | Marczyk | Oct 2008 | B1 |
| 7434715 | Shelton, IV et al. | Oct 2008 | B2 |
| 7434716 | Viola | Oct 2008 | B2 |
| 7455208 | Wales et al. | Nov 2008 | B2 |
| 7455676 | Holsten et al. | Nov 2008 | B2 |
| 7461767 | Viola et al. | Dec 2008 | B2 |
| 7464846 | Shelton, IV et al. | Dec 2008 | B2 |
| 7464847 | Viola et al. | Dec 2008 | B2 |
| 7464849 | Shelton, IV et al. | Dec 2008 | B2 |
| 7467740 | Shelton, IV et al. | Dec 2008 | B2 |
| 7472814 | Mastri et al. | Jan 2009 | B2 |
| 7472815 | Shelton, IV et al. | Jan 2009 | B2 |
| 7472816 | Holsten et al. | Jan 2009 | B2 |
| 7481348 | Marczyk | Jan 2009 | B2 |
| 7481349 | Holsten et al. | Jan 2009 | B2 |
| 7487899 | Shelton, IV et al. | Feb 2009 | B2 |
| 7490749 | Schall et al. | Feb 2009 | B2 |
| 7506790 | Shelton, IV | Mar 2009 | B2 |
| 7506791 | Omaits et al. | Mar 2009 | B2 |
| 7513408 | Shelton, IV et al. | Apr 2009 | B2 |
| 7530484 | Durrani | May 2009 | B1 |
| 7543730 | Marczyk | Jun 2009 | B1 |
| 7543731 | Green et al. | Jun 2009 | B2 |
| 7546940 | Milliman et al. | Jun 2009 | B2 |
| 7549564 | Boudreaux | Jun 2009 | B2 |
| 7552854 | Wixey et al. | Jun 2009 | B2 |
| 7556186 | Milliman | Jul 2009 | B2 |
| 7565993 | Milliman et al. | Jul 2009 | B2 |
| 7568604 | Ehrenfels et al. | Aug 2009 | B2 |
| 7588174 | Holsten et al. | Sep 2009 | B2 |
| 7588175 | Timm et al. | Sep 2009 | B2 |
| 7588177 | Racenet | Sep 2009 | B2 |
| 7604151 | Hess et al. | Oct 2009 | B2 |
| 7611038 | Racenet et al. | Nov 2009 | B2 |
| 7617961 | Viola | Nov 2009 | B2 |
| 7624902 | Marczyk et al. | Dec 2009 | B2 |
| 7631793 | Rethy et al. | Dec 2009 | B2 |
| 7635074 | Olson et al. | Dec 2009 | B2 |
| 7637409 | Marczyk | Dec 2009 | B2 |
| 7637410 | Marczyk | Dec 2009 | B2 |
| 7641091 | Olson et al. | Jan 2010 | B2 |
| 7641093 | Doll et al. | Jan 2010 | B2 |
| 7641095 | Viola | Jan 2010 | B2 |
| 7644848 | Swayze et al. | Jan 2010 | B2 |
| 7648055 | Marczyk | Jan 2010 | B2 |
| 7651017 | Ortiz et al. | Jan 2010 | B2 |
| 7654431 | Hueil et al. | Feb 2010 | B2 |
| 7658311 | Boudreaux | Feb 2010 | B2 |
| 7665647 | Shelton, IV et al. | Feb 2010 | B2 |
| 7669746 | Shelton, IV | Mar 2010 | B2 |
| 7670334 | Hueil et al. | Mar 2010 | B2 |
| 7673781 | Swayze et al. | Mar 2010 | B2 |
| 7682367 | Shah et al. | Mar 2010 | B2 |
| 7690547 | Racenet et al. | Apr 2010 | B2 |
| 7703653 | Shah et al. | Apr 2010 | B2 |
| 7717312 | Beetel | May 2010 | B2 |
| 7721931 | Shelton, IV et al. | May 2010 | B2 |
| 7721933 | Ehrenfels et al. | May 2010 | B2 |
| 7721935 | Racenet et al. | May 2010 | B2 |
| 7721936 | Shelton, IV et al. | May 2010 | B2 |
| 7726538 | Holsten et al. | Jun 2010 | B2 |
| 7726539 | Holsten et al. | Jun 2010 | B2 |
| 7731073 | Wixey et al. | Jun 2010 | B2 |
| 7735703 | Morgan et al. | Jun 2010 | B2 |
| 7753245 | Boudreaux et al. | Jul 2010 | B2 |
| 7753246 | Scirica | Jul 2010 | B2 |
| 7757925 | Viola et al. | Jul 2010 | B2 |
| 7766210 | Shelton, IV et al. | Aug 2010 | B2 |
| 7770774 | Mastri et al. | Aug 2010 | B2 |
| 7780054 | Wales | Aug 2010 | B2 |
| 7780055 | Scirica et al. | Aug 2010 | B2 |
| 7784662 | Wales et al. | Aug 2010 | B2 |
| 7784663 | Shelton, IV | Aug 2010 | B2 |
| 7793812 | Moore et al. | Sep 2010 | B2 |
| 7798386 | Schall et al. | Sep 2010 | B2 |
| 7810693 | Broehl et al. | Oct 2010 | B2 |
| 7815090 | Marczyk | Oct 2010 | B2 |
| 7815091 | Marczyk | Oct 2010 | B2 |
| 7819298 | Hall et al. | Oct 2010 | B2 |
| 7819896 | Racenet | Oct 2010 | B2 |
| 7823760 | Zemlok et al. | Nov 2010 | B2 |
| 7828188 | Jankowski | Nov 2010 | B2 |
| 7828189 | Holsten et al. | Nov 2010 | B2 |
| 7837079 | Holsten et al. | Nov 2010 | B2 |
| 7837081 | Holsten et al. | Nov 2010 | B2 |
| 7845534 | Viola et al. | Dec 2010 | B2 |
| 7845535 | Scircia | Dec 2010 | B2 |
| 7845537 | Shelton, IV et al. | Dec 2010 | B2 |
| 7857184 | Viola | Dec 2010 | B2 |
| 7857185 | Swayze et al. | Dec 2010 | B2 |
| 7857187 | Milliman | Dec 2010 | B2 |
| 7861906 | Doll et al. | Jan 2011 | B2 |
| 7866525 | Scirica | Jan 2011 | B2 |
| 7866527 | Hall et al. | Jan 2011 | B2 |
| 7891534 | Wenchell et al. | Feb 2011 | B2 |
| 7905381 | Baxter, III et al. | Mar 2011 | B2 |
| 7909220 | Viola | Mar 2011 | B2 |
| 7909221 | Viola et al. | Mar 2011 | B2 |
| 7913891 | Doll et al. | Mar 2011 | B2 |
| 7914543 | Roth et al. | Mar 2011 | B2 |
| 7918230 | Whitman et al. | Apr 2011 | B2 |
| 7918376 | Knodel et al. | Apr 2011 | B1 |
| 7918377 | Measamer et al. | Apr 2011 | B2 |
| 7922063 | Zemlok et al. | Apr 2011 | B2 |
| 7934628 | Wenchell et al. | May 2011 | B2 |
| 7934629 | Wixey et al. | May 2011 | B2 |
| 7934630 | Shelton, IV et al. | May 2011 | B2 |
| 7942300 | Rethy et al. | May 2011 | B2 |
| 7954685 | Viola | Jun 2011 | B2 |
| 7954686 | Baxter, III et al. | Jun 2011 | B2 |
| 7959050 | Smith et al. | Jun 2011 | B2 |
| 7963433 | Whitman et al. | Jun 2011 | B2 |
| 7992758 | Whitman et al. | Aug 2011 | B2 |
| 8002795 | Beetel | Aug 2011 | B2 |
| 8006887 | Marczyk | Aug 2011 | B2 |
| 8007513 | Nalagatla et al. | Aug 2011 | B2 |
| 8008598 | Whitman et al. | Aug 2011 | B2 |
| 8011550 | Aranyi et al. | Sep 2011 | B2 |
| 8011553 | Mastri et al. | Sep 2011 | B2 |
| 8012170 | Whitman et al. | Sep 2011 | B2 |
| 8016178 | Olson et al. | Sep 2011 | B2 |
| 8020742 | Marczyk | Sep 2011 | B2 |
| 8020743 | Shelton, IV | Sep 2011 | B2 |
| 8028885 | Smith et al. | Oct 2011 | B2 |
| 8033438 | Scirica | Oct 2011 | B2 |
| 8033440 | Wenchell et al. | Oct 2011 | B2 |
| 8033441 | Marczyk | Oct 2011 | B2 |
| 8033442 | Racenet et al. | Oct 2011 | B2 |
| 8034077 | Smith et al. | Oct 2011 | B2 |
| 8038046 | Smith et al. | Oct 2011 | B2 |
| 8052024 | Viola et al. | Nov 2011 | B2 |
| 8056788 | Mastri et al. | Nov 2011 | B2 |
| 8056789 | White et al. | Nov 2011 | B1 |
| 8061576 | Cappola | Nov 2011 | B2 |
| 8061577 | Racenet et al. | Nov 2011 | B2 |
| 8070033 | Milliman et al. | Dec 2011 | B2 |
| 8070034 | Knodel | Dec 2011 | B1 |
| 8070035 | Holsten et al. | Dec 2011 | B2 |
| 8070036 | Knodel | Dec 2011 | B1 |
| 8074861 | Ehrenfels et al. | Dec 2011 | B2 |
| 8083118 | Milliman et al. | Dec 2011 | B2 |
| 8087563 | Milliman et al. | Jan 2012 | B2 |
| 8091753 | Viola | Jan 2012 | B2 |
| 8091754 | Ehrenfels et al. | Jan 2012 | B2 |
| 8092493 | Marczyk | Jan 2012 | B2 |
| 8100309 | Marczyk | Jan 2012 | B2 |
| 8113406 | Holsten et al. | Feb 2012 | B2 |
| 8113407 | Holsten et al. | Feb 2012 | B2 |
| 8113408 | Wenchell et al. | Feb 2012 | B2 |
| 8113410 | Hall et al. | Feb 2012 | B2 |
| 8118207 | Racenet et al. | Feb 2012 | B2 |
| 8123100 | Holsten et al. | Feb 2012 | B2 |
| 8127976 | Scirica et al. | Mar 2012 | B2 |
| 8136712 | Zingman | Mar 2012 | B2 |
| 8152041 | Kostrzewski | Apr 2012 | B2 |
| 8157145 | Shelton, IV et al. | Apr 2012 | B2 |
| 8157150 | Viola et al. | Apr 2012 | B2 |
| 8157152 | Holsten et al. | Apr 2012 | B2 |
| 8181839 | Beetel | May 2012 | B2 |
| 8186555 | Shelton, IV et al. | May 2012 | B2 |
| 8186556 | Viola | May 2012 | B2 |
| 8186560 | Hess et al. | May 2012 | B2 |
| 8191752 | Scirica | Jun 2012 | B2 |
| 8196795 | Moore et al. | Jun 2012 | B2 |
| 8201721 | Zemlok et al. | Jun 2012 | B2 |
| 8205619 | Shah et al. | Jun 2012 | B2 |
| 8205780 | Sorrentino et al. | Jun 2012 | B2 |
| 8205781 | Baxter, III et al. | Jun 2012 | B2 |
| 8210411 | Yates et al. | Jul 2012 | B2 |
| 8210416 | Milliman et al. | Jul 2012 | B2 |
| 8220688 | Laurent et al. | Jul 2012 | B2 |
| 8225979 | Farascioni et al. | Jul 2012 | B2 |
| 8231040 | Zemlok et al. | Jul 2012 | B2 |
| 8231041 | Marczyk et al. | Jul 2012 | B2 |
| 8235274 | Cappola | Aug 2012 | B2 |
| 8236010 | Ortiz et al. | Aug 2012 | B2 |
| 8240536 | Marczyk | Aug 2012 | B2 |
| 8240537 | Marczyk | Aug 2012 | B2 |
| 8241322 | Whitman et al. | Aug 2012 | B2 |
| 8245898 | Smith et al. | Aug 2012 | B2 |
| 8245899 | Swensgard et al. | Aug 2012 | B2 |
| 8245900 | Scirica | Aug 2012 | B2 |
| 8256656 | Milliman et al. | Sep 2012 | B2 |
| 8272552 | Holsten et al. | Sep 2012 | B2 |
| 8272554 | Whitman et al. | Sep 2012 | B2 |
| 8281972 | Wixey et al. | Oct 2012 | B2 |
| 8281973 | Wenchell et al. | Oct 2012 | B2 |
| 8286846 | Smith et al. | Oct 2012 | B2 |
| 8292146 | Holsten et al. | Oct 2012 | B2 |
| 8292148 | Viola | Oct 2012 | B2 |
| 8292151 | Viola | Oct 2012 | B2 |
| 8292152 | Milliman et al. | Oct 2012 | B2 |
| 8292153 | Jankowski | Oct 2012 | B2 |
| 8292157 | Smith et al. | Oct 2012 | B2 |
| 8308041 | Kostrzewski | Nov 2012 | B2 |
| 8308043 | Bindra et al. | Nov 2012 | B2 |
| 8317070 | Hueil et al. | Nov 2012 | B2 |
| 8322455 | Shelton, IV et al. | Dec 2012 | B2 |
| 8336754 | Cappola et al. | Dec 2012 | B2 |
| 8342377 | Milliman et al. | Jan 2013 | B2 |
| 8342378 | Marczyk et al. | Jan 2013 | B2 |
| 8342379 | Whitman et al. | Jan 2013 | B2 |
| 8342380 | Viola | Jan 2013 | B2 |
| 8348125 | Viola et al. | Jan 2013 | B2 |
| 8348129 | Bedi et al. | Jan 2013 | B2 |
| 8348131 | Omaits et al. | Jan 2013 | B2 |
| 8353440 | Whitman et al. | Jan 2013 | B2 |
| 8360297 | Shelton, IV et al. | Jan 2013 | B2 |
| 8360299 | Zemlok et al. | Jan 2013 | B2 |
| 8393513 | Jankowski | Mar 2013 | B2 |
| 8397972 | Kostrzewski | Mar 2013 | B2 |
| 8397973 | Hausen | Mar 2013 | B1 |
| 8403198 | Sorrentino et al. | Mar 2013 | B2 |
| 8413868 | Cappola | Apr 2013 | B2 |
| 8414577 | Boudreaux et al. | Apr 2013 | B2 |
| 8418906 | Farascioni et al. | Apr 2013 | B2 |
| 8418907 | Johnson et al. | Apr 2013 | B2 |
| 8418908 | Beardsley | Apr 2013 | B1 |
| 8419768 | Marczyk | Apr 2013 | B2 |
| 8439246 | Knodel | May 2013 | B1 |
| 8444036 | Shelton, IV | May 2013 | B2 |
| 8453907 | Laurent et al. | Jun 2013 | B2 |
| 8453912 | Mastri et al. | Jun 2013 | B2 |
| 8453913 | Milliman | Jun 2013 | B2 |
| 8459520 | Giordano et al. | Jun 2013 | B2 |
| 8459522 | Marczyk | Jun 2013 | B2 |
| 8464922 | Marczyk | Jun 2013 | B2 |
| 8469252 | Holcomb et al. | Jun 2013 | B2 |
| 8479967 | Marczyk | Jul 2013 | B2 |
| 8496152 | Viola | Jul 2013 | B2 |
| 8496155 | Knodel | Jul 2013 | B2 |
| 8496156 | Sniffin et al. | Jul 2013 | B2 |
| 8496683 | Prommersberger et al. | Jul 2013 | B2 |
| 8505799 | Viola et al. | Aug 2013 | B2 |
| 8505801 | Ehrenfels et al. | Aug 2013 | B2 |
| 8517239 | Scheib et al. | Aug 2013 | B2 |
| 8517240 | Mata et al. | Aug 2013 | B1 |
| 8523043 | Ullrich et al. | Sep 2013 | B2 |
| 8540130 | Moore et al. | Sep 2013 | B2 |
| 8540133 | Bedi et al. | Sep 2013 | B2 |
| 8540625 | Miyoshi | Sep 2013 | B2 |
| 8544712 | Jankowski | Oct 2013 | B2 |
| 8556151 | Viola | Oct 2013 | B2 |
| 8556152 | Marczyk et al. | Oct 2013 | B2 |
| 8556153 | Knodel | Oct 2013 | B1 |
| 8561871 | Rajappa et al. | Oct 2013 | B2 |
| 8561874 | Scirica | Oct 2013 | B2 |
| 8573459 | Smith et al. | Nov 2013 | B2 |
| 8573460 | Cappola | Nov 2013 | B2 |
| 8573462 | Smith et al. | Nov 2013 | B2 |
| 8573463 | Scirica et al. | Nov 2013 | B2 |
| 8573464 | Nalagatla et al. | Nov 2013 | B2 |
| 8579176 | Smith et al. | Nov 2013 | B2 |
| 8579177 | Beetel | Nov 2013 | B2 |
| 8584919 | Hueil et al. | Nov 2013 | B2 |
| 8584921 | Scirica | Nov 2013 | B2 |
| 8596513 | Olson | Dec 2013 | B2 |
| 8608043 | Scirica | Dec 2013 | B2 |
| 8608045 | Smith et al. | Dec 2013 | B2 |
| 8616427 | Viola | Dec 2013 | B2 |
| 8622274 | Yates et al. | Jan 2014 | B2 |
| 8627992 | Edoga et al. | Jan 2014 | B2 |
| 8627993 | Smith et al. | Jan 2014 | B2 |
| 8627995 | Smith et al. | Jan 2014 | B2 |
| 8631990 | Park et al. | Jan 2014 | B1 |
| 8632525 | Kerr et al. | Jan 2014 | B2 |
| 8632535 | Shelton, IV et al. | Jan 2014 | B2 |
| 8636189 | Knodel et al. | Jan 2014 | B1 |
| 8636190 | Zemlok et al. | Jan 2014 | B2 |
| 8636192 | Farascioni et al. | Jan 2014 | B2 |
| 8636193 | Whitman et al. | Jan 2014 | B2 |
| 8636762 | Whitman et al. | Jan 2014 | B2 |
| 8636766 | Milliman et al. | Jan 2014 | B2 |
| 8657174 | Yates et al. | Feb 2014 | B2 |
| 8657176 | Shelton, IV et al. | Feb 2014 | B2 |
| 8657178 | Hueil et al. | Feb 2014 | B2 |
| 8672209 | Crainich | Mar 2014 | B2 |
| 8672951 | Smith et al. | Mar 2014 | B2 |
| 8685004 | Zemlock et al. | Apr 2014 | B2 |
| 8695865 | Smith et al. | Apr 2014 | B2 |
| 8696665 | Hunt et al. | Apr 2014 | B2 |
| 8708211 | Zemlok et al. | Apr 2014 | B2 |
| 8708213 | Shelton, IV et al. | Apr 2014 | B2 |
| 8740034 | Morgan et al. | Jun 2014 | B2 |
| 8740035 | Mastri et al. | Jun 2014 | B2 |
| 8740036 | Williams | Jun 2014 | B2 |
| 8752748 | Whitman et al. | Jun 2014 | B2 |
| 8763876 | Kostrzewski | Jul 2014 | B2 |
| 8770458 | Scirica | Jul 2014 | B2 |
| 8770459 | Racenet et al. | Jul 2014 | B2 |
| 8789741 | Baxter, III et al. | Jul 2014 | B2 |
| 8800839 | Beetel | Aug 2014 | B2 |
| 8800840 | Jankowski | Aug 2014 | B2 |
| 8800841 | Ellerhorst et al. | Aug 2014 | B2 |
| 8806973 | Ross et al. | Aug 2014 | B2 |
| 8807414 | Ross et al. | Aug 2014 | B2 |
| 8820603 | Shelton, IV et al. | Sep 2014 | B2 |
| 8820608 | Miyamoto | Sep 2014 | B2 |
| 8833631 | Munro, III et al. | Sep 2014 | B2 |
| 8840003 | Morgan et al. | Sep 2014 | B2 |
| 8858571 | Shelton, IV et al. | Oct 2014 | B2 |
| 8875971 | Hall et al. | Nov 2014 | B2 |
| 8875972 | Weisenburgh, II et al. | Nov 2014 | B2 |
| 8887979 | Mastri et al. | Nov 2014 | B2 |
| 8899462 | Kostrzewski et al. | Dec 2014 | B2 |
| 8899463 | Schall et al. | Dec 2014 | B2 |
| 8905288 | Wenchell | Dec 2014 | B2 |
| 8920435 | Smith et al. | Dec 2014 | B2 |
| 8925783 | Zemlok et al. | Jan 2015 | B2 |
| 8931679 | Kostrzewski | Jan 2015 | B2 |
| 8931683 | Racenet et al. | Jan 2015 | B2 |
| 8939343 | Milliman et al. | Jan 2015 | B2 |
| 8967444 | Beetel | Mar 2015 | B2 |
| 8967446 | Beardsley et al. | Mar 2015 | B2 |
| 8967447 | Hartoumbekis | Mar 2015 | B2 |
| 8968276 | Zemlok et al. | Mar 2015 | B2 |
| 8973803 | Hall et al. | Mar 2015 | B2 |
| 8979827 | Cappola | Mar 2015 | B2 |
| 9004340 | Scirica | Apr 2015 | B2 |
| 9010611 | Ross et al. | Apr 2015 | B2 |
| 9016541 | Viola et al. | Apr 2015 | B2 |
| 9016545 | Aranyi et al. | Apr 2015 | B2 |
| 9022271 | Scirica | May 2015 | B2 |
| 9023014 | Chowaniec et al. | May 2015 | B2 |
| 9027817 | Milliman et al. | May 2015 | B2 |
| 9027818 | Scirica et al. | May 2015 | B2 |
| 9033202 | Scirica | May 2015 | B2 |
| 9038880 | Donohoe | May 2015 | B1 |
| 9055943 | Zemlok et al. | Jun 2015 | B2 |
| 9072515 | Hall et al. | Jul 2015 | B2 |
| 9084601 | Moore et al. | Jul 2015 | B2 |
| 9101358 | Kerr et al. | Aug 2015 | B2 |
| 9161813 | Benamou | Oct 2015 | B2 |
| 9204876 | Cappola et al. | Dec 2015 | B2 |
| 9237890 | Kostrzewski | Jan 2016 | B2 |
| 9265585 | Wingardner et al. | Feb 2016 | B2 |
| 9282966 | Shelton, IV et al. | Mar 2016 | B2 |
| 9386984 | Aronhalt et al. | Jul 2016 | B2 |
| 9402629 | Ehrenfels et al. | Aug 2016 | B2 |
| 9510830 | Shelton, IV et al. | Dec 2016 | B2 |
| 9532782 | Kostrzewski | Jan 2017 | B2 |
| 9662108 | Williams | May 2017 | B2 |
| 9737302 | Shelton, IV et al. | Aug 2017 | B2 |
| 9737303 | Shelton, IV et al. | Aug 2017 | B2 |
| 9797486 | Zergiebel et al. | Oct 2017 | B2 |
| 20020025243 | Heck | Feb 2002 | A1 |
| 20020029044 | Monassevitch et al. | Mar 2002 | A1 |
| 20020062136 | Hillstead | May 2002 | A1 |
| 20020120279 | Deguillebon et al. | Aug 2002 | A1 |
| 20030130677 | Whitman et al. | Jul 2003 | A1 |
| 20040006372 | Racenet et al. | Jan 2004 | A1 |
| 20040138705 | Heino et al. | Jul 2004 | A1 |
| 20050203504 | Wham | Sep 2005 | A1 |
| 20050234478 | Wixey | Oct 2005 | A1 |
| 20060097026 | Shelton, IV | May 2006 | A1 |
| 20060100644 | Viola | May 2006 | A1 |
| 20060180634 | Shelton, IV et al. | Aug 2006 | A1 |
| 20060235442 | Huitema | Oct 2006 | A1 |
| 20060289602 | Wales et al. | Dec 2006 | A1 |
| 20070034664 | Jiang | Feb 2007 | A1 |
| 20070039997 | Mather et al. | Feb 2007 | A1 |
| 20070057014 | Whitman et al. | Mar 2007 | A1 |
| 20070068990 | Shelton, IV et al. | Mar 2007 | A1 |
| 20070084897 | Shelton, IV et al. | Apr 2007 | A1 |
| 20070102472 | Shelton, IV | May 2007 | A1 |
| 20070119901 | Ehrenfels et al. | May 2007 | A1 |
| 20070131732 | Holsten et al. | Jun 2007 | A1 |
| 20070173803 | Wham | Jul 2007 | A1 |
| 20070173811 | Couture | Jul 2007 | A1 |
| 20070175950 | Shelton, IV et al. | Aug 2007 | A1 |
| 20070175951 | Shelton, IV et al. | Aug 2007 | A1 |
| 20080029574 | Shelton et al. | Feb 2008 | A1 |
| 20080029575 | Shelton et al. | Feb 2008 | A1 |
| 20080041918 | Holsten et al. | Feb 2008 | A1 |
| 20080078807 | Hess et al. | Apr 2008 | A1 |
| 20080083807 | Beardsley et al. | Apr 2008 | A1 |
| 20080169333 | Shelton et al. | Jul 2008 | A1 |
| 20080179375 | Scirica | Jul 2008 | A1 |
| 20080255607 | Zemlok | Oct 2008 | A1 |
| 20090001129 | Marczyk | Jan 2009 | A1 |
| 20090001130 | Hess et al. | Jan 2009 | A1 |
| 20090026245 | Holsten et al. | Jan 2009 | A1 |
| 20090048589 | Takashino et al. | Feb 2009 | A1 |
| 20090057369 | Smith et al. | Mar 2009 | A1 |
| 20090090763 | Zemlok et al. | Apr 2009 | A1 |
| 20090143806 | Witt et al. | Jun 2009 | A1 |
| 20090182321 | McGreevy | Jul 2009 | A1 |
| 20090198272 | Kerver et al. | Aug 2009 | A1 |
| 20090206131 | Weisenburgh, II et al. | Aug 2009 | A1 |
| 20090206133 | Morgan et al. | Aug 2009 | A1 |
| 20090206137 | Hall et al. | Aug 2009 | A1 |
| 20090277948 | Beardsley et al. | Nov 2009 | A1 |
| 20090277949 | Viola et al. | Nov 2009 | A1 |
| 20100069942 | Shelton, IV | Mar 2010 | A1 |
| 20100072258 | Farascioni et al. | Mar 2010 | A1 |
| 20100089970 | Smith et al. | Apr 2010 | A1 |
| 20100168624 | Sliwa | Jul 2010 | A1 |
| 20100193566 | Scheib et al. | Aug 2010 | A1 |
| 20100230465 | Smith et al. | Sep 2010 | A1 |
| 20100331820 | Prisco et al. | Dec 2010 | A1 |
| 20110036892 | Marczyk et al. | Feb 2011 | A1 |
| 20110042440 | Holsten et al. | Feb 2011 | A1 |
| 20110087276 | Bedi et al. | Apr 2011 | A1 |
| 20110108601 | Clark et al. | May 2011 | A1 |
| 20110108603 | Racenet et al. | May 2011 | A1 |
| 20110121049 | Malinouskas et al. | May 2011 | A1 |
| 20110125138 | Malinouskas et al. | May 2011 | A1 |
| 20110127185 | Ward | Jun 2011 | A1 |
| 20110139852 | Zingman | Jun 2011 | A1 |
| 20110147433 | Shelton, IV et al. | Jun 2011 | A1 |
| 20110155784 | Shelton, IV et al. | Jun 2011 | A1 |
| 20110155787 | Laurent et al. | Jun 2011 | A1 |
| 20110208183 | Stockert | Aug 2011 | A1 |
| 20110290851 | Shelton, IV et al. | Dec 2011 | A1 |
| 20110290853 | Shelton, IV et al. | Dec 2011 | A1 |
| 20120061446 | Knodel et al. | Mar 2012 | A1 |
| 20120074198 | Huitema et al. | Mar 2012 | A1 |
| 20120074200 | Schmid et al. | Mar 2012 | A1 |
| 20120078243 | Worrell et al. | Mar 2012 | A1 |
| 20120080482 | Schall et al. | Apr 2012 | A1 |
| 20120080498 | Shelton, IV et al. | Apr 2012 | A1 |
| 20120091182 | Marczyk | Apr 2012 | A1 |
| 20120109186 | Parrott et al. | May 2012 | A1 |
| 20120168487 | Holsten et al. | Jul 2012 | A1 |
| 20120193396 | Zemlok et al. | Aug 2012 | A1 |
| 20120203247 | Shelton, IV et al. | Aug 2012 | A1 |
| 20120211542 | Racenet | Aug 2012 | A1 |
| 20120239009 | Mollere et al. | Sep 2012 | A1 |
| 20120253298 | Henderson et al. | Oct 2012 | A1 |
| 20120286022 | Olson et al. | Nov 2012 | A1 |
| 20120296238 | Chernov | Nov 2012 | A1 |
| 20120318844 | Shelton, IV et al. | Dec 2012 | A1 |
| 20120325893 | Pastorelli et al. | Dec 2012 | A1 |
| 20130001270 | Kostrzewski | Jan 2013 | A1 |
| 20130012958 | Marczyk et al. | Jan 2013 | A1 |
| 20130015229 | Viola | Jan 2013 | A1 |
| 20130015230 | Wixey et al. | Jan 2013 | A1 |
| 20130015232 | Smith et al. | Jan 2013 | A1 |
| 20130015233 | Viola | Jan 2013 | A1 |
| 20130020375 | Shelton, IV et al. | Jan 2013 | A1 |
| 20130037595 | Gupta et al. | Feb 2013 | A1 |
| 20130048697 | Shelton, IV et al. | Feb 2013 | A1 |
| 20130056521 | Swensgard | Mar 2013 | A1 |
| 20130079814 | Hess et al. | Mar 2013 | A1 |
| 20130087603 | Viola | Apr 2013 | A1 |
| 20130092717 | Marczyk et al. | Apr 2013 | A1 |
| 20130098964 | Smith et al. | Apr 2013 | A1 |
| 20130098965 | Kostrzewski et al. | Apr 2013 | A1 |
| 20130098969 | Scirica et al. | Apr 2013 | A1 |
| 20130105545 | Burbank | May 2013 | A1 |
| 20130105547 | Beardsley | May 2013 | A1 |
| 20130105548 | Hodgkinson et al. | May 2013 | A1 |
| 20130105549 | Holsten et al. | May 2013 | A1 |
| 20130112730 | Whitman et al. | May 2013 | A1 |
| 20130112731 | Hodgkinson | May 2013 | A1 |
| 20130126583 | Hueil et al. | May 2013 | A1 |
| 20130126586 | Zhang et al. | May 2013 | A1 |
| 20130146640 | Jankowski | Jun 2013 | A1 |
| 20130172928 | Kostrzewski | Jul 2013 | A1 |
| 20130172929 | Hess et al. | Jul 2013 | A1 |
| 20130175317 | Yates et al. | Jul 2013 | A1 |
| 20130175322 | Yates et al. | Jul 2013 | A1 |
| 20130184718 | Smith et al. | Jul 2013 | A1 |
| 20130186931 | Beardsley | Jul 2013 | A1 |
| 20130186932 | Shelton, IV et al. | Jul 2013 | A1 |
| 20130186933 | Shelton, IV et al. | Jul 2013 | A1 |
| 20130193188 | Shelton, IV et al. | Aug 2013 | A1 |
| 20130200132 | Moore et al. | Aug 2013 | A1 |
| 20130206816 | Penna | Aug 2013 | A1 |
| 20130214025 | Zemlok et al. | Aug 2013 | A1 |
| 20130221065 | Aronhalt et al. | Aug 2013 | A1 |
| 20130240604 | Knodel | Sep 2013 | A1 |
| 20130248582 | Scirica | Sep 2013 | A1 |
| 20130256370 | Smith et al. | Oct 2013 | A1 |
| 20130256371 | Shelton, IV | Oct 2013 | A1 |
| 20130270321 | Marczyk | Oct 2013 | A1 |
| 20130270323 | Marczyk | Oct 2013 | A1 |
| 20130284789 | Smith et al. | Oct 2013 | A1 |
| 20130284791 | Olson et al. | Oct 2013 | A1 |
| 20130299552 | Viola | Nov 2013 | A1 |
| 20130306702 | Viola et al. | Nov 2013 | A1 |
| 20130306703 | Ehrenfels et al. | Nov 2013 | A1 |
| 20130306706 | Knodel | Nov 2013 | A1 |
| 20130313303 | Shelton, IV et al. | Nov 2013 | A1 |
| 20130327809 | Shelton, IV et al. | Dec 2013 | A1 |
| 20130327810 | Swayze et al. | Dec 2013 | A1 |
| 20130334278 | Kerr et al. | Dec 2013 | A1 |
| 20130334280 | Krehel et al. | Dec 2013 | A1 |
| 20130334281 | Williams | Dec 2013 | A1 |
| 20130334283 | Swayze et al. | Dec 2013 | A1 |
| 20130334284 | Swayze et al. | Dec 2013 | A1 |
| 20130334285 | Swayze et al. | Dec 2013 | A1 |
| 20130334286 | Swayze et al. | Dec 2013 | A1 |
| 20130334287 | Shelton, IV | Dec 2013 | A1 |
| 20130334288 | Shelton, IV | Dec 2013 | A1 |
| 20140014704 | Onukuri et al. | Jan 2014 | A1 |
| 20140014707 | Onukuri et al. | Jan 2014 | A1 |
| 20140021239 | Kostrzewski | Jan 2014 | A1 |
| 20140025046 | Williams et al. | Jan 2014 | A1 |
| 20140025061 | Benamou | Jan 2014 | A1 |
| 20140027491 | Beardsley et al. | Jan 2014 | A1 |
| 20140027493 | Jankowski | Jan 2014 | A1 |
| 20140042204 | Beetel | Feb 2014 | A1 |
| 20140058382 | Yang | Feb 2014 | A1 |
| 20140103092 | Kostrzewski et al. | Apr 2014 | A1 |
| 20140103093 | Koch, Jr. et al. | Apr 2014 | A1 |
| 20140107640 | Yates et al. | Apr 2014 | A1 |
| 20140110453 | Wingardner et al. | Apr 2014 | A1 |
| 20140131416 | Whitman et al. | May 2014 | A1 |
| 20140135832 | Park et al. | May 2014 | A1 |
| 20140151433 | Shelton, IV et al. | Jun 2014 | A1 |
| 20140151434 | Shelton, IV et al. | Jun 2014 | A1 |
| 20140158746 | Mastri et al. | Jun 2014 | A1 |
| 20140166727 | Swayze et al. | Jun 2014 | A1 |
| 20140175146 | Knodel | Jun 2014 | A1 |
| 20140175149 | Smith et al. | Jun 2014 | A1 |
| 20140203063 | Hessler et al. | Jul 2014 | A1 |
| 20140205637 | Widenhouse et al. | Jul 2014 | A1 |
| 20140224856 | Smith et al. | Aug 2014 | A1 |
| 20140236173 | Scirica et al. | Aug 2014 | A1 |
| 20140236184 | Leimbach | Aug 2014 | A1 |
| 20140239038 | Leimbach et al. | Aug 2014 | A1 |
| 20140239041 | Zerkle et al. | Aug 2014 | A1 |
| 20140239044 | Hoffman | Aug 2014 | A1 |
| 20140246474 | Hall et al. | Sep 2014 | A1 |
| 20140246475 | Hall et al. | Sep 2014 | A1 |
| 20140246478 | Baber et al. | Sep 2014 | A1 |
| 20140246479 | Baber et al. | Sep 2014 | A1 |
| 20140260746 | Sakaguchi et al. | Sep 2014 | A1 |
| 20140263537 | Leimbach et al. | Sep 2014 | A1 |
| 20140263539 | Leimbach et al. | Sep 2014 | A1 |
| 20140263541 | Leimbach et al. | Sep 2014 | A1 |
| 20140263542 | Leimbach et al. | Sep 2014 | A1 |
| 20140263543 | Leimbach et al. | Sep 2014 | A1 |
| 20140263545 | Williams et al. | Sep 2014 | A1 |
| 20140263546 | Aranyi | Sep 2014 | A1 |
| 20140263550 | Aranyi et al. | Sep 2014 | A1 |
| 20140263553 | Leimbach et al. | Sep 2014 | A1 |
| 20140263554 | Leimbach et al. | Sep 2014 | A1 |
| 20140263555 | Hufnagel et al. | Sep 2014 | A1 |
| 20140263559 | Williams et al. | Sep 2014 | A1 |
| 20140263562 | Patel et al. | Sep 2014 | A1 |
| 20140263564 | Leimbach et al. | Sep 2014 | A1 |
| 20140263565 | Lytle, IV et al. | Sep 2014 | A1 |
| 20140263566 | Williams et al. | Sep 2014 | A1 |
| 20140263567 | Williams et al. | Sep 2014 | A1 |
| 20140263568 | Williams et al. | Sep 2014 | A1 |
| 20140263569 | Williams et al. | Sep 2014 | A1 |
| 20140263570 | Hopkins et al. | Sep 2014 | A1 |
| 20140263571 | Morgan et al. | Sep 2014 | A1 |
| 20140263572 | Shelton, IV et al. | Sep 2014 | A1 |
| 20140284372 | Kostrzewski | Sep 2014 | A1 |
| 20140291378 | Shelton, IV et al. | Oct 2014 | A1 |
| 20140299649 | Shelton, IV et al. | Oct 2014 | A1 |
| 20140305986 | Hall et al. | Oct 2014 | A1 |
| 20140305988 | Boudreaux et al. | Oct 2014 | A1 |
| 20140305992 | Kimsey et al. | Oct 2014 | A1 |
| 20140305994 | Parihar et al. | Oct 2014 | A1 |
| 20140353359 | Hall et al. | Dec 2014 | A1 |
| 20150008248 | Giordano et al. | Jan 2015 | A1 |
| 20150034697 | Mastri et al. | Feb 2015 | A1 |
| 20150041518 | Shelton, IV et al. | Feb 2015 | A1 |
| 20150053738 | Morgan et al. | Feb 2015 | A1 |
| 20150053740 | Shelton, IV | Feb 2015 | A1 |
| 20150053741 | Shelton, IV et al. | Feb 2015 | A1 |
| 20150053742 | Shelton, IV et al. | Feb 2015 | A1 |
| 20150053743 | Yates et al. | Feb 2015 | A1 |
| 20150053744 | Swayze et al. | Feb 2015 | A1 |
| 20150053745 | Yates et al. | Feb 2015 | A1 |
| 20150053746 | Shelton, IV et al. | Feb 2015 | A1 |
| 20150053748 | Yates et al. | Feb 2015 | A1 |
| 20150053749 | Shelton, IV et al. | Feb 2015 | A1 |
| 20150054753 | Morgan et al. | Feb 2015 | A1 |
| 20150060516 | Collings et al. | Mar 2015 | A1 |
| 20150060517 | Williams | Mar 2015 | A1 |
| 20150060521 | Weisenburgh, II et al. | Mar 2015 | A1 |
| 20150076205 | Zergiebel | Mar 2015 | A1 |
| 20150076206 | Sapre | Mar 2015 | A1 |
| 20150076209 | Shelton, IV et al. | Mar 2015 | A1 |
| 20150076210 | Shelton, IV et al. | Mar 2015 | A1 |
| 20150076212 | Shelton, IV | Mar 2015 | A1 |
| 20150083781 | Giordano et al. | Mar 2015 | A1 |
| 20150083783 | Shelton, IV et al. | Mar 2015 | A1 |
| 20150090760 | Giordano et al. | Apr 2015 | A1 |
| 20150090761 | Giordano et al. | Apr 2015 | A1 |
| 20150090762 | Giordano et al. | Apr 2015 | A1 |
| 20150090764 | Zemlok et al. | Apr 2015 | A1 |
| 20150108201 | Williams | Apr 2015 | A1 |
| 20150122872 | Olson et al. | May 2015 | A1 |
| 20150127046 | Peterson | May 2015 | A1 |
| 20150129631 | Beetel | May 2015 | A1 |
| 20150129634 | Shelton, IV et al. | May 2015 | A1 |
| 20150133995 | Shelton, IV et al. | May 2015 | A1 |
| 20150133996 | Shelton, IV et al. | May 2015 | A1 |
| 20150134076 | Shelton, IV et al. | May 2015 | A1 |
| 20150144678 | Hall et al. | May 2015 | A1 |
| 20150196349 | Wham | Jul 2015 | A1 |
| 20150201935 | Weisenburgh, II et al. | Jul 2015 | A1 |
| 20150208902 | Okamoto | Jul 2015 | A1 |
| 20150245834 | Scirica et al. | Sep 2015 | A1 |
| 20150272576 | Cappola | Oct 2015 | A1 |
| 20150272657 | Yates | Oct 2015 | A1 |
| 20150289873 | Shelton, IV et al. | Oct 2015 | A1 |
| 20150297221 | Kerr et al. | Oct 2015 | A1 |
| 20150297233 | Huitema et al. | Oct 2015 | A1 |
| 20150380187 | Zergieebel et al. | Dec 2015 | A1 |
| 20160000439 | Weisenburgh, II et al. | Jan 2016 | A1 |
| 20160000440 | Weisenburgh, II et al. | Jan 2016 | A1 |
| 20160058447 | Posada et al. | Mar 2016 | A1 |
| 20160058492 | Yates et al. | Mar 2016 | A1 |
| 20160183948 | Shelton, IV et al. | Jun 2016 | A1 |
| 20160199125 | Jones | Jul 2016 | A1 |
| 20160310204 | McHenry et al. | Oct 2016 | A1 |
| 20160338702 | Ehrenfels et al. | Nov 2016 | A1 |
| 20160374672 | Bear et al. | Dec 2016 | A1 |
| 20160374675 | Shelton, IV et al. | Dec 2016 | A1 |
| 20170007241 | Shelton, IV et al. | Jan 2017 | A1 |
| 20170007242 | Shelton, IV et al. | Jan 2017 | A1 |
| 20170007243 | Shelton, IV et al. | Jan 2017 | A1 |
| 20170007249 | Shelton, IV et al. | Jan 2017 | A1 |
| 20170042604 | McFarland | Feb 2017 | A1 |
| 20170231633 | Marczyk et al. | Aug 2017 | A1 |
| 20170245856 | Baxter, III et al. | Aug 2017 | A1 |
| 20170245858 | Williams | Aug 2017 | A1 |
| 20170281161 | Shelton, IV et al. | Oct 2017 | A1 |
| 20170281165 | Harris et al. | Oct 2017 | A1 |
| 20170281168 | Shelton, IV et al. | Oct 2017 | A1 |
| 20170290583 | Reed et al. | Oct 2017 | A1 |
| 20170290584 | Jasemian et al. | Oct 2017 | A1 |
| 20190000533 | Messerly | Jan 2019 | A1 |
| 20190261984 | Nelson et al. | Aug 2019 | A1 |
| 20200268381 | Roberts et al. | Aug 2020 | A1 |
| 20220000539 | Shah | Jan 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 0 251 444 | Jan 1988 | EP |
| 0 492 283 | Jul 1992 | EP |
| 0 514 139 | Nov 1992 | EP |
| 0 536 903 | Apr 1993 | EP |
| 0 596 543 | May 1994 | EP |
| 1 523 944 | Apr 2005 | EP |
| 1 759 812 | Mar 2007 | EP |
| 1 915 953 | Apr 2008 | EP |
| 1 479 348 | Jul 2008 | EP |
| 2 044 893 | Sep 2008 | EP |
| 2 005 902 | Dec 2008 | EP |
| 2 090 241 | Aug 2009 | EP |
| 2 263 568 | Dec 2010 | EP |
| 2 361 562 | Aug 2011 | EP |
| 2 462 875 | Jun 2012 | EP |
| 2 486 859 | Aug 2012 | EP |
| 2 764 833 | Aug 2014 | EP |
| 2 772 192 | Sep 2014 | EP |
| 2 777 530 | Sep 2014 | EP |
| 2 815 705 | Dec 2014 | EP |
| 2 923 661 | Mar 2015 | EP |
| 2 853 204 | Apr 2015 | EP |
| 2 891 462 | Jul 2015 | EP |
| 2 926 742 | Oct 2015 | EP |
| 2 942 020 | Nov 2015 | EP |
| 2 959 851 | Dec 2015 | EP |
| 3 135 225 | Mar 2017 | EP |
| 3 238 639 | Mar 2017 | EP |
| 3 338 653 | Jun 2018 | EP |
| 3 338 698 | Jun 2018 | EP |
| 3 338 702 | Jun 2018 | EP |
| 2001-087272 | Apr 2001 | JP |
| 2063710 | Jul 1996 | RU |
| WO 8302247 | Jul 1983 | WO |
| WO 9424947 | Nov 1994 | WO |
| WO 0230296 | Apr 2002 | WO |
| WO 02096327 | Dec 2002 | WO |
| WO 2003094747 | Nov 2003 | WO |
| WO 2004032762 | Apr 2004 | WO |
| WO 2012052729 | Apr 2012 | WO |
| WO 2014139440 | Sep 2014 | WO |
| WO 2020077531 | Apr 2020 | WO |
| Entry |
|---|
| International Searching Authority/ EPO, Invitation to Pay Additional Fees and Communication Relating to the Results of the Partial International Search for PCT/US2021/057365, entitled “Surgical Stapler Having a Powered Handle,” dated Feb. 23, 2022, 14 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2021/057278, entitled “Actuation Shaft Retention Mechanism for Surgical Stapler” dated Feb. 23, 2022, 15 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2021/057231, entitled “Material Combinations and Processing Methods for a Surgical Instrument” dated Feb. 11, 2022, 15 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 20197859.0, entitled “Surgical Stapler with Circumferential Firing,” dated Jan. 28, 2021, 13 pgs. |
| European Patent Office, The International Search Report and Written Opinion for International Application No. PCT/US2020/067540, dated May 3, 2021, entitled “Electrosurgical System with Tissue and Maximum Current Identification,” 12 pages. |
| European Patent Office, Extended European Search Report for European Application No. EP 21162419.2, entitled “Surgical Stapler Having Articulation Mechanism,” dated Jun. 22, 2021, 10 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2020/025496 entitled “Reload Cover for Surgical System,” dated Oct. 14, 2021, 12 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 21173771.3, entitled “Reload Shaft Assembly for Surgical Stapler,” dated Aug. 27, 2021, 10 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 21195788.1, entitled “Surgical Stapler with Self-Adjusting Staple Height,” dated Dec. 13, 2021, 9 pgs. |
| European Patent Office, European Search Report for European Application No. 07784007.2, entitled “Surgical Stapler,” dated Jun. 15, 2012, 6 pgs. |
| Ethicon Endo Surgery, Inc., Contour Curved Cutter Stapler, 2014, 2 pgs. |
| Justright Surgical, JustRight Surgery, Dec. 31, 2014, 2 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2014/028811, entitled “Surgical Stapler Having Actuation Mechanism with Rotatable Shaft,” dated Aug. 5, 2014, 14 pgs. |
| European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2014/028211, entitled “Surgical Stapler with Partial Pockets,” dated Sep. 8, 2014, 17 pgs. |
| International Searching Authority, U.S., The International Search Report and the Written Opinion of the International Searching authority for international application PCT/US2014/027768, titled “Surgical Stapler with Expandable Jaw”, dated Jul. 25, 2014, 17 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2014/028811, entitled “Surgical Stapler Having Actuation Mechanism with Rotatable Shaft,” dated Sep. 15, 2015, 11 pgs. |
| International Searching Authority, U.S., The International Search Report and the Written Opinion of the International Searching authority for international application PCT/US2015/0035379, titled “Surgical Stapler with Circumferential Firing”, dated Sep. 15, 2015, 22 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2014/027768, entitled “Surgical Stapler with Expandable Jaw,” dated Sep. 24, 2015, 9 pgs. |
| European Patent Office, International Search Report and Written Opinion for International Application No. PCT/US2015/050103 titled “Surgical Stapler with Self-Adjusting Staple Height” dated Feb. 17, 2016, 18 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/035379, entitled “Surgical Stapler with Circumferential Firing,” dated Dec. 22, 2016, 14 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2015/050103, titled “Surgical Stapler With Self-Adjusting Staple Height,” dated Mar. 30, 2017, 12 pgs. |
| European Patent Office, European Search Report for European Application No. EP14764812.5, entitled “Surgical Stapler Having Actuation Mechanism with Rotatable Shaft,” dated Apr. 6, 2017, 6 pgs. |
| International Searching Authority/ EPO, Invitation to Pay Additional Fees and Communication Relating to the Results of the Partial International Search for PCT/US2017/027269, entitled “Reload Shaft Assembly for Surgical Stapler,” dated Jun. 28, 2017, 15 pgs. |
| International Searching Authority/ EPO, Invitation to Pay Additional Fees and Communication Relating to the Results of the Partial International Search for PCT/US2017/027213, entitled “Surgical Stapler Having a Powered Handle,” dated Jul. 5, 2017, 11 pgs. |
| International Searching Authority/ EPO, Invitation to Pay Additional Fees and Communication Relating to the Results of the Partial International Search for PCT/US2017/027142, entitled “Surgical Stapler Having Articulation Mechanism,” dated Jul. 10, 2017, 15 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2017/027269, entitled “Reload Shaft Assembly for Surgical Stapler,” dated Sep. 12, 2017, 22 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2017/027213, entitled “Surgical Stapler Having a Powered Handle,” dated Sep. 13, 2017, 17 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2017/027142, entitled “Surgical Stapler Having Articulation Mechanism,” dated Sep. 14, 2017, 21 pgs. |
| European Patent Office, The International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2016/045993 titled “Surgical Stapler Having Locking Articulation Joint”, dated Jan. 24, 2017, 20 pgs. |
| European Patent Office, Partial European Search Report for European Application No. EP 14762896.0, entitled “Surgical Stapler with Expandable Jaw,” dated Apr. 10, 2017, 6 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2016/045993, entitled “Surgical Stapler Having Locking Articulation Joint,” dated Feb. 15, 2018, 13 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 18186558.5, entitled “Surgical Stapler with Partial Pockets,” dated Oct. 10, 2018, 9 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2017/027142, entitled “Surgical Stapler Having Articulation Mechanism,” dated Oct. 25, 2018, 12 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2017/027213, entitled “Surgical Stapler Having Powered Handle,” dated Oct. 25, 2018, 9 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2017/027269, entitled “Reload Shaft Assembly for Surgical Stapler,” dated Oct. 25, 2018, 12 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 18189960.0, entitled “Surgical Stapler with Expandable Jaw,” dated Dec. 13, 2018, 6 pgs. |
| International Searching Authority/ EPO, Invitation to Pay Additional Fees and Communication Relating to the Results of the Partial International Search for PCT/US2019/019867, entitled “Surgical Stapler Having a Powered Handle,” dated May 24, 2019, 19 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2019/019867, entitled “Surgical Stapler Having a Powered Handle,” dated Jul. 19, 2019, 24 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 19150575.9, entitled “Surgical Stapler Having Actuation Mechanism with Rotatable Shaft,” dated Aug. 21, 2019, 5 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 19180055.6, entitled “Surgical Stapler with Circumferential Firing,” dated Sep. 20, 2019, 8 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2020/019938, entitled “Surgical Stapling Instrument Having a Two-Position Mechanism,” dated Jun. 18, 2020, 16 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 20157713.7, entitled “Surgical Stapler with Expandable Jaw,” dated May 11, 2020, 6 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 20161294.2, entitled “Surgical Stapler with Self-Adjusting Staple Height,” dated Jun. 22, 2020, 6 pgs. |
| International Searching Authority/ EPO, Invitation to Pay Additional Fees for PCTUS2020/025496, entitled “Reload Cover for Surgical Stapling System,” dated Jun. 18, 2019, 15 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2020/025496, entitled “Reload Cover for Surgical Stapling System,” dated Aug. 13, 2020, 20 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2019/019867, entitled “Surgical Stapler Having a Powered Handle,” dated Sep. 3, 2020, 16 pgs. |
| International Preliminary Examining Authority/US, International Preliminary Report on Patentability for International Application No. PCT/US2020/067540, titled “Electrosurgical System with Tissue and Maximum Current Identification,” dated Jul. 14, 2022, 9 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2021/057365, entitled “Surgical Stapler Having a Powered Handle” dated Apr. 13, 2022, 21 pgs. |
| European Patent Office, The International Search Report and the Written Opinion of the International Searching Authority for International Application No. PCT/US2022/012252, entitled “Surgical Stapler Having Shaft Recognition Mechanism” dated Apr. 13, 2022, 13 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2020/019938, entitled “Surgical Stapler Having a Two-Position Lockout Mechanism,” dated Sep. 10, 2020, 10 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 22196603.9, entitled “Surgical Stapler with Expandable Jaw,” dated Dec. 14, 2022, 6 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 22203464.7, entitled “Surgical Stapler with Partial Pockets,” dated Dec. 20, 2022, 9 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 22203599.0, entitled “Surgical Stapler Having a Powered Handle,” dated Feb. 7, 2023, 7 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, forInternational Application No. PCT/US2021/057231, entitled “Material Combinations and Processing Methods for a Surgical Instrument,” dated May 11, 2023, 10 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, forInternational Application No. PCT/US2021/057278, entitled “Actuation Shaft Retention Mechanism for Surgical Stapler,” dated May 11, 2023, 10 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2021/057365, entitled “Surgical Stapler Having a Powered Handle,” dated May 11, 2023, 14 pgs. |
| The International Bureau of WIPO, International Preliminary Report on Patentability, for International Application No. PCT/US2022/012452, entitled “Surgical Stapler Having Shaft Recognition Mechanism,” dated Jul. 27, 2023, 8 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 23185918.2, entitled “Surgical Stapler Having Actuation Mechanism with Rotatable Shaft,” dated Sep. 22, 2023, 5 pgs. |
| European Patent Office, Extended European Search Report for European Application No. EP 23198045.9, entitled “Reload Shaft Assembly for Surgical Stapler,” dated Oct. 25, 2023, 12 pgs. |
| Number | Date | Country | |
|---|---|---|---|
| 20210196368 A1 | Jul 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62955758 | Dec 2019 | US |
